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 Rotaviruses are a leading cause of severe, life-threatening diarrhea worldwide, 
primarily in infants and young children. Interferon induction is a key protective host 
defense mechanism triggered during viral infection, and to combat this response, 
rotaviruses encode the primary interferon antagonist non-structural protein 1 (NSP1). 
Expression of NSP1 proteins from diverse rotavirus strains is associated with a decrease 
in interferon induction, and depending on host species and virus strain, may achieve this 
result by facilitating the degradation of various host signaling proteins. Most human and 
porcine strains, including the rotavirus strain OSU, encode an NSP1 capable of 
facilitating the degradation of β-TrCP, a key regulator of NF-κB-mediated interferon 
induction. β-TrCP acts as a substrate adaptor protein of cellular E3 ubiquitin ligases, and 
by directing degradation of IκB (inhibitor of kappa B), allows NF-κB to translocate to the 
nucleus to induce interferon responses. β-TrCP recognizes and binds a phosphorylated 
degron (phosphodegron) motif (DSGϕxS) within IκB, and other cellular proteins, to 
facilitate degradation. The C-terminus of OSU NSP1 harbors a mimic of this motif 
(DSGIS) that allows for binding and sequestration of β-TrCP. In our studies, we have 
found that like IκB, NSP1 is phosphorylated and requires phosphorylation for β-TrCP 
engagement. Unlike IκB, NSP1 is a substrate of casein kinase II (CKII). NSP1 is a 
substrate adaptor protein of cullin-RING ligases (CRLs), and while NSP1 appears to 
engage cullin 3 via an N-terminal RING domain, C-terminal degron phosphorylation is 
required for NSP1 incorporation into CRLs. Interestingly, NSP1 proteins that engage 
interferon response factor (IRF) proteins are able to engage these substrates without 
phosphorylation. These data suggest that NSP1 proteins may inhibit interferon induction 
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through binding and sequestration alone, without the specific need for degradation of 
substrates. Furthermore, many viruses are known to encode proteins that directly engage 
and direct β-TrCP activity. β-TrCP regulates stability of proteins involved in a number of 
pathways beyond simply interferon induction, including mTOR. Our studies indicate that 
OSU infection results in accumulation of DEPTOR, a β-TrCP substrate and negative 
regulator of mTOR complexes. Analysis of mTOR signaling cascades suggests that 
control of β-TrCP may result in a pro-viral cellular environment with benefits to viruses 
beyond promoting rotavirus replication.  
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Public health considerations of rotavirus  
Acute viral gastroenteritis is a major public health concern worldwide, and illness 
is associated with high annual mortality. Gastroenteritis is associated with diarrhea, 
vomiting, and severe dehydration, and can be particularly serious for young children in 
developing countries. A main cause of viral gastroenteritis is rotavirus, a genus of non-
enveloped double-stranded RNA (dsRNA) viruses from the Reoviridae family.   
Rotaviruses were initially recognized as a major cause of gastroenteritis in 
humans in 1974 (1), but their discovery as animal pathogens predates this finding by a 
full decade (2). Since their initial identification, rotaviruses of human and veterinary 
concern have been discovered in the young of many mammalian species, including mice, 
rats, pigs, cows, dogs, and bats, in addition to some bird species. Rotavirus infection 
predominantly occurs in the young of affected species, and symptoms can lead to severe 
debilitating malnourishment or death. An estimated 1.3 million children under the age of 
five die annually because of diarrheal disease (3), and rotavirus is predicted to account 
for 37% of deaths due to gastroenteritis in young children (4). Over two million children 
have died as a result of rotavirus infection in the last 10 years alone, and infections are 
estimated to cause upwards of 125 million symptomatic human infections each year (5, 
6).  
Vaccines have recently been made available for both human and veterinary use; 
however the efficacy of prophylactic vaccination has been met with variable results and 
with apparent geographical inconsistency. Severe disease occurs disproportionately in 
underdeveloped countries, with 90% of human deaths occurring in Asia and Africa, and 
over half in four specific countries (Democratic Republic of Congo, India, Nigeria, and 
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Pakistan). Almost 22% of these deaths occur in India alone (4). Accordingly, since the 
introduction and continued use of vaccines in developing countries, it is estimated that 
the number of global rotavirus-related deaths has declined between 2000 and 2013 to 
215,000 annually (4).  
Prior to the introduction of rotavirus vaccines in the US in 2006, rotavirus-related 
medical costs totaled near $300 million each year (7). The use of a pentavalent human-
bovine reassortant vaccine (RotaTeq, RV5; Merck & Co) and a monovalent vaccine 
(Rotarix, RV1; GSK) has been successful in reducing this burden in the US and other 
developed countries (8, 9). In clinical trials, vaccines decreased hospitalizations and 
emergency room visits by almost 95% (9), and vaccine effectiveness approaching 100% 
(10, 11) has been reported in similar higher-income countries. However, similar results 
for vaccine programs in developing countries have not been observed, and specifics 
contributing to these differences remain unclear. In low-income countries, where 
vaccines offer the greatest lifesaving potential, vaccine efficacy remains at only 40-60% 
(6).  
Symptoms and pathology associated with rotavirus infection have been well 
described in infected hosts of diverse species. Rotavirus is transmitted primarily via the 
fecal-oral route, and incubation periods are typically 1-2 days following initial exposure. 
Infection spreads from the small bowel to the ileum over 1-2 days (12), and most 
infection and viral replication occurs within mature enterocytes at villus tips of the small 
intestine. This infection cycle is rapidly lytic and leads to disruption of the gut 
epithelium, as well as shortening of villi and crypt hyperplasia (13). In addition to 
compromised absorption within the small intestine, hypersecretion caused by the 
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rotavirus enterotoxin (NSP4; see page 28) is thought to contribute to diarrheal disease 
phenotypes (14). Vomiting may precede symptoms of diarrhea, which together, may last 
for 5 days. Death of infected individuals most often occurs because of severe dehydration 
and cardiovascular failure. Symptoms can be easily treated and alleviated in developed 
countries, largely because of access to medical intervention and rehydration measures, 
but deaths are a common outcome in less developed areas of the world.  
 
Rotavirus classification 
 The genus Rotavirus is one of 15 genera of the Reoviridae family. Within this 
genus, rotaviruses are geneticallly and antigenically diverse, and can be divided into at 
least eight groups or species, A-H (15, 16). Rotavirus group A (RVA) is the major cause 
of pathogenic human infections, and includes genotypes specified by the primary 
antigenic proteins of the virus. These include the surface and spike proteins of the virus, 
VP4 (P-type, for protease sensitive protein) and VP7 (G-type, for glycoprotein). A more 
extensive genotyping system has been developed that incorporates all 11 genome 
segments of the virus and is based on nucleotide sequence diversity, rather than serotype 
or genotype (17-19). Table 1-1 demonstrates the nomenclature utilized to denote each 
genome segment and associated protein(s).  
 
Rotavirus particle structure 
 The architecture of rotavirus virions reflects the close relationship between 
replication cycle and the structure of these particles. Mature, infectious particles consist 
of three concentric protein layers encasing 11 distinct dsRNA genome segments. These  
 
 5 
Protein Acronym Function 
VP7 G Glycosylated 
VP4 P Protease-sensitive 
VP6 I Inner capsid 
VP1 R RNA-dependent RNA polymerase 
VP2 C Core protein 
VP3 M Methyltransferase 
NSP1 A Interferon antagonist 
NSP2 N NTPase 
NSP3 T Translation enhancer 
NSP4 E Enterotoxin 
NSP5 H Phosphoprotein 
 












segments code for six non-structural proteins (NSP1-NSP6) (Table 1-2) that aid in viral 
replication, assembly, and evasion of host antiviral defense mechanisms, and six 
structural proteins (VP1-VP4, VP6-VP7) (Table 1-3) that form the icosahedral, triple-
layered particles (TLPs) (Fig. 1-1, A). TLPs are non-enveloped and by cryo-EM, have a 
wheel-like appearance that gives rise to the name of the genus (latin, rota) (1). The 
outermost layer of the particle is formed by trimers of VP7 (780 molecules) arranged 
with T=13 symmetry, and is studded with protruding VP4 multimeric spikes (60 
molecules). Upon trypsin activation, VP4 is cleaved into VP8* and VP5*, the latter 
which anchors the spike in the shell of the virion. Both VP5* and VP7 make contacts 
with the intermediate layer, formed by trimers of VP6 (green, Fig. 1-1, B). Below this 
layer is the inner core shell (blue, Fig. 1-1, B), consisting of 60 VP2 capsid protein 
dimers (one each of conformation A and B) organized with T=1 symmetry (20).  
VP2 dimers are arranged as decamers at each axis of five-fold symmetry (Fig. 1-
1, C), with flexible N-terminal arms (~100 residues) that protrude into the center of the 
particle. Within the VP2 core shell and associated with each decamer is one copy each of 
the VP1 RNA-dependent-RNA-polymerase (RdRp) and the VP3 capping enzyme (Fig. 1-
1, D) (21). Data suggests that VP1 sits slightly off center from the five-fold axis (22); the 
structure of VP3, which is suggested to sit adjacent to VP1, remains largely unsolved. 
VP2 N-terminal arms (Fig. 1-1, E, red arrows), too, are structurally unresolved, but their 
flexibility and non-specific ssRNA binding affinity, in addition to their requirement for 
activation of VP1 (23), suggest a role in assembly, encapsidation, or mediation of RNA 
synthesis events. VP1 and VP3, in addition to contacts with VP2, form functional 








Protein Size (aa; 
kDa) 
Localization Function 
5 1519 NSP1 486; 58 Cytoplasm Interferon antagonist, 
RNA binding 
7 1016 NSP3 313; 35 Cytoplasm Translation inhibitor 




assortment & assembly 
10 700 NSP4 175; 28 ER Enterotoxin, DLP ER 
translocation 
11 631 NSP5 197; 21 Cytoplasm, 
viroplasm 
Viroplasm formation 
(11) (631) (NSP6) (51; 12) (Cytoplasm) (RNA binding) 
 
Table 1-2. Rotavirus non-structural proteins, adapted for rotavirus strain OSU (RVA/Pig-













1 3271 VP1 1088; 
125 
Core 12 RdRp 
2 2683 VP2 890; 100 Core 120 Core shell, RdRp 
regulation 





4 2336 VP4 776; 85 Outer layer 180 Receptor 
attachment, cleaved 
to VP4 and VP8 
6 1315 VP6 397; 45 Intermediate 
layer 
780 Structural integrity 
9 1023 VP7 326; 37 Outer layer 780 Structural integrity, 
receptor binding 
 
Table 1-3. Rotavirus structural proteins, adapted for rotavirus strain OSU (RVA/Pig-





By close examination, the rotavirus virion shell is perforated with pores and 
channels that align with axes of symmetry. Virions have 132 channels that constitute 
three classes.  Twelve of these channels (Class I) are located at axes of five-fold 
symmetry, in alignment with VP1 and VP3 in the inner core shell (24, 25). Class II 
channels pass through axes of three-fold symmetry (60 channels) and Class III channels 
exist at axes of two-fold symmetry (60 channels). Because rotavirus particles do not 
entirely disassemble in the cytoplasm of infected cells, these channels likely play 
valuable roles in nucleotide exchange and extrusion of nascent positive-sense RNAs 
(+RNAs) from transcriptionally active particles. 
 
Rotavirus genome structure and organization  
The segmented, dsRNA genome of rotavirus is approximately 18.5 kilobases (kb) 
in total, and is comprised of segments ranging in size from 0.5 to 3.3 kb. Within the 
rotavirus particle, the genome segments form contacts with replication complexes, with 
each segment interacting with an individual VP1 RdRp. RNAs produced by VP1 from 
individual genome segments within the particle exit through Type I channels, and data 
suggests each channel is specific for a single mRNA (26). These assignments are thought 
to be consistently arranged and maintained between particles (26). This inter-particle 
genomic organization is likely shared with other dsRNA viruses within the Reoviridae 
family, such as blue tongue virus (27).  
It has been postulated that genome segments within the particle are arranged to 
form conical cylinders, increasing in diameter from the center of the particle to the distal 
interior boundary where contacts can be made with VP1 (20, 28). The genomic RNA in 
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TLPs is thought to be held in a rigid, peri-crystalline state, as the preferred geometry of 
dsRNA is to form a rigid rod. By cryo-EM, curved, concentric layers of RNA can be 
observed in the interior of actively transcribing particles (Fig. 1-1, E) (29). While atomic 
resolution structures of double- and triple-layered particles (DLPs, TLPs) have revealed 
in fine detail the organization within and between capsid protein layers, much less 
information is available describing the organization of the dsRNA within these particles. 
While genome segments vary in length and composition, they share prototypical 
organization. Each segment is arranged as a central ORF with conserved 5’ and 3’ 
untranslated regions (UTR) terminal sequences. These ORFs are monocistronic, except 
for some RV strains which encode a second protein from genome segment 11 (30). The 
UTR sequences range from 9-48 nucleotides at the 5’ end and 17-182 nucleotides at the 
3’ terminus. These ends are partial inversions with complementarity and likely facilitate 
long-range interactions in single-stranded (ss) +RNAs, which fold to form panhandle-like 
structures (31). The 3’ UTR sequence UGUGACC engages the VP1 RdRp and VP3 (32, 
33), and likely interacts with NSP3 during translation (34). During replication, segments 
are modified through the addition of a 5’ cap structure (m7GppG) mediated by the VP3 





Figure 1-1. Rotavirus particle structure, adapted from Gridley & Patton (29). 
(a) A mature rotavirus virion (TLP), with VP7 in yellow, VP4 in red. Arrows point to 
Type I, II, and III channels. (b) Under the outer VP4/VP7 layer is the intermediate VP6 
layer (green), and the innermost VP2 core shell (blue). (c) The inner core shell is formed 
by 12 decamers of VP2, each constructed of 5 copies each of VP2 folded in conformation 
A and B. Type I channels run through the center of each decamer , the center of five 
VP2-A molecules (yellow asterisk), and Type II channels sit at the inner tip of VP2-B 
molecules (blue asterisk). (c) On the underside of each decamer, within the core, one VP1 
RdRp (pink) and one VP3 molecule (purple) associate with VP2 proteins. Unstructured 
VP2 tethers are shown as yellow ribbons, and extend 80-100 residues. (c) A slice of a 
cryo-EM image of a mature TLP, colored to reflect individual protein layers (yellow 
VP7, green VP6, blue VP2). dsRNA density appears as concentric rings within the 
particle. A portion of the VP2 tethers can be observed (red arrows). Additional density at 




Rotavirus replication cycle 
Overview 
In the gastrointestinal tract, exposure of virions to trypsin-like proteases cleaves 
VP4 spikes (red, Fig. 1-2) into VP5* and VP8* to yield infectious virions capable of 
entry into target cells. The outer shell capsid proteins facilitate virion attachment to cells 
via sialic acid and other specific cellular surface receptors. Most rotavirus strains enter 
cells by clathrin-mediated endocytosis (36). Low calcium concentrations in endosomes 
trigger membrane penetration and shedding of the outer virion shell to yield double-
layered particles (DLPs), activating the encapsidated replication complexes to transcribe 
from dsRNA genome segments. Transcripts (+RNAs) are translated to produce viral 
proteins, or accumulate in viroplasms with other viral components to act as templates for 
minus-strand (-RNA) replication. Replication occurs as the +RNA strands interact with 
VP1 and VP3 via the conserved 3’ UTR, and commences as the VP2 core shell engages 
the VP1 RdRp. The intermediate VP6 layer assembles on the core to form a DLP, which 
buds into the ER and acquires a VP4/VP7 layer before egress via lysis or in exosomal 
membrane bound packets. This has has been observed for other RNA viruses to enhance 
transmission and reassortment (37).  
 
Adsorption 
 Rotavirus infection occurs primarily in mature enterocytes at the epithelial tips of 
intestinal microvilli, and adsorption and entry into these cells is a complex, multistep 





Figure 1-2. Overview of rotavirus life cycle, from Trask, et al. (24).  Rotavirus virions 
attach to target cells through VP8* (red) interactions with surface receptors such as sialic 
acid. Virions enter through various endocytic processes, and in early endosomes, low 
calcium concentrations allow uncoating of VP7 (yellow), and subsequent membrane 
penetration. Released DLPs are transcriptionally active, and ssRNAs produced by VP1 
and capped by VP3 serve as templates or replication (minus strand synthesis). Proximal 
to the ER, NSP2 and NSP5 form viroplasms where replication, assortment, and assembly 
take place; VP1, VP2, and VP3 interact with RNAs during the assortment process 
(mediated by NSP2), and assemble into viral cores coated by VP6, forming DLPs. DLPs 
bind NSP4 on the ER surface, mediating entry into the ER lumen, where they acquire a 
VP4 and VP7 layer. Assembled TLPs are released from cells by exocytosis or lysis, and 





































encounter trypsin-like proteases in order to be infectious; trypsin cleavage of VP4 yields 
VP5* and VP8*. This cleavage process uncovers a shallow groove on the surface of 
VP8* that can bind sialic acid residues, and rotaviruses can be divided based on 
preference for a terminal or internal sialic residue. Internal sialic acid is insensitive to 
neauraminidase treatment, thus resulting in “neuraminidase-resistant” classification for 
some strains, such as human DS-1 and Wa (38). Most human strains are neuraminidase 
resistant, whereas some animal strains require sialic acid for attachment (39). Some VP8* 
additionally bind to non-sialic acid containing histo blood group antigens via a Galβ1-
GlcNAc motif (40-42). These strains have either H-type or A-type glycan binding 
specificity (40). Some strains also require a functioning FUT2 enzyme (43), which is 
crucial in mediating entry of other enteric pathogens, such as norovirus.  
VP5* and VP7 glycoproteins mediate interactions with most co-receptors, such as 
integrins (α2β1, αvβ3, αxβ2, α4β1) (39). Rotavirus may also interact with the heat shock 
cognate protein hsc70, although the order of events mediating coreceptor interaction and 
their roles in attachment and entry are less defined (36, 44, 45). All known co-receptors 
are associated with lipid rafts, and these detergent resistant membrane regions are 
required to facilitate rotavirus entry (39, 46). The relative importance of the various 
receptors and coreceptors continues to be addressed (47). It is of particular interest that 
silencing, blocking, or inhibiting all known receptors and cofactors reduces rotavirus 
infectivity by less than 1 log (48), suggesting there may be additional pertinent factors 






The process by which rotavirus particles enter cells is contentious, but many 
studies have emphasized the importance of VP4 trypsin cleavage in entry (49, 50). Prior 
to cleavage, VP4 spikes are flexible, but their structure is nearly identical to the more 
rigid post-cleavage VP4 (49). Following binding to cellular receptors, spikes undergo 
conformational changes to expose lipophilic domains of VP5* (51), a transition favored 
by the post-cleavage VP4 (49). Following binding and conformational transition, entry 
steps are less clear. Rotavirus was initially thought to enter cells through direct 
penetration (52), although more recent data suggests that diverse endocytic pathways are 
recruited for this process and vary by virus strain. Most human and animal strains enter 
cells via clathrin-mediated endocytosis (36) (53), but the simian virus RRV, an integrin-
dependent neuraminidase-sensitive strain, uses an alternative endocytic pathway and is 
independent of clathrin and caveolin (36, 54). VP4 is likely responsible for observed 
endocytic pathway preference differences (36) (53). Regardless of strain and pathway, 
however, RNAi screens confirm the role of multiple endosomal sorting complex required 
for transport (ESCRT) pathway machinery in rotavirus entry processes (55). 
Upon internalization, and regardless of the entry pathway utilized, rotavirus 
particles enter maturing endosomes. Virus strains require the formation of intraluminal 
vesicles (ILVs), characteristic structures of maturing endosomes, that are formed by 
ESCRT machinery (56). While RRV only requires maturing endosomes, those viruses 
that enter via clathrin-mediated endocytosis must also migrate to late endosomes to 
establish infection (57). In this cellular compartment, low Ca2+ ion concentrations lead to 
solublization of the outer capsid layer, yielding double-layered particles (DLPs) (58). 
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Beyond this change in virion composition, the precise mechanism of membrane 
penetration remains unclear, but it appears to be a rapid process associated with 
membrane disruption and gross morphological changes (59).  
 
Transcription 
Loss of the outer capsid proteins during particle entry leads to membrane 
penetration and the release of transcriptionally active double-layered particles (DLP) into 
the cytoplasm. These particles rapidly diffuse inward, away from the site of initial entry. 
Dissociation of the outer VP4 and VP7 capsid layer allows for expansion of the particle 
and of the Type I channels (60), through which nascent RNAs are extruded.  DLPs are 
transcriptionally active both in the cytoplasm and in vitro, and these particles are capable 
of generating large amounts of RNA, within the mg range (60, 61). Experiments with 
fluorescently-tagged particles suggest that the uncoating efficiency of membrane-bound 
virions can reach up to 50%, and that RNA synthesis can be detected as early as 15 
minutes post infection (p.i.) (62); RNA synthesis by even a single particle is sufficient to 
initiate infection. 
Within DLPs, each VP1 polymerase, paired with a VP3 methyltransferase, 
interacts with a VP2 decamer to initiate transcription (24, 63). Each of these transcription 
complexes interacts with a single dsRNA genome segment (26) to produce positive sense 
ssRNAs with a 5’ cap structure (m7GppG) that are not poly-adenylated (35) (Fig. 1-3, a, 
b, c). Newly generated ssRNAs serve as templates for translation and as templates for 
replication upon packaging into newly forming particles (32). 
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The VP1 polymerase is a hollow, channeled, globular enzyme with a conserved 
right-handed polymerase domain. The N- and C-terminal domains associated with this 
protein are well-conserved and are unique to the RdRp enzymes of the Reoviridae. Four 
channels lead to the catalytic center of the enzyme, and serve as entry and exit sites for 
nucleotides, template RNAs, and for nascent RNA products (Figure 1-3, c). VP1 
transcription is a conservative process; negative-sense genomic RNA enters through one 
channel towards the catalytic center and exits through a second channel towards the 
particle core where it reanneals with genomic positive-sense RNA. Nascent positive-
sense ssRNAs are directed out a third channel towards VP3 (61). The fourth channel 
serves as an entry site for NTPs.  
Despite advances in research describing transcriptionally active rotavirus 
particles, it remains uncertain how structural changes within entering virions and the 
transition from TLP to DLP induce transcription. It is clear that removal of the outer  
capsid shell has structural consequences resulting in the expansion of the DLP and its exit 
channels in a process that can be reversed through in vitro recoating of these particles 
(64, 65). Retention of the VP6 intermediate layer is crucial for VP1 transcriptional 
activation (66), and antibodies that bind to this layer can be inhibitory for transcriptional 
activity (67). It is currently unknown whether additional changes are required to initiate 
transcription within the particle, or if initiation results simply due to the increase in 
particle diameter. Interestingly, the amount of ssRNA made per dsRNA template is not 
equimolar (68, 69), and the relationship or coordination between replication complexes 
within particles has not been fully explored. Whether active complexes are synchronized 






Figure 1-3. A model for rotavirus transcription, from Trask, et al. (24). During the entry 
process, particles lose the outer VP7 layer (yellow) (a), releasing a DLP (b) into the core. 
Loss of this layer allows for expansion of the particle and of exit channels through the 
VP2 (blue) and VP6 (green) layers, permitting extrusion of nascent RNA transcripts, 
generated by VP1 from the dsRNA templates within the core. (c) Four channels run 
through the RdRp, allowing for entry of a minus strand template, entry of NTPs, exit of 
nealy formed ssRNAs, and exit of the template strand to reanneal with its positive-sense 
pair. New ssRNAs are capped by VP3 prior to extrusion from the particle through the 
Type I channel at the center of each VP2 decamer (blue pentagram). VP3 has domains 





additional rounds of transcription that occur during particle formation, not just from post-
entry DLPs (69). 
 
Viroplasms & Assortment  
 Little is known about the processes that govern rotavirus assortment and 
packaging intermediates, in part because these processes take place in electron-dense 
structures called viroplasms (70). Viroplasms are formed through the activities of NSP2 
and NSP5, and while colocalization of these proteins and structures is clear, details 
outlining their formation processes are scarce. NSP2 is an octameric, RNA-binding 
protein (71) that interacts directly with the NSP5 phosphoprotein (72, 73), which is 
largely disordered and remains unsolved. Exogenous expression of NSP2 and NSP5 in 
the absence of active infection is sufficient to drive formation of viroplasm structures 
(74). Because it is hypothesized that the location of nascent viral ssRNAs determines 
their role as either translation or replication templates, it has been suggested that 
viroplasms function to sequester viral RNAs and proteins to drive assembly; indeed, viral 
ssRNAs associated with these structures are selectively packaged and replicated within 
newly assembling viral cores (75). Additionally, the number and size of viroplasms 
increase in a manner that correlates with multiplicity of infection (MOI) (76), but whether 
these structures form directly at points nucleated by entering virions or form 
independently by another process remains unclear.  
  Genome replication is known to be coupled with assembly, but the lack of in vitro 
packaging assays and only recent availability of a reverse genetics system (77) has made 
these processes difficult to study. Studies with other members of the Reoviriae suggest 
 
 19 
that assortment is governed by RNA-RNA interactions, and data supporting this model 
may be valid for rotavirus as well (78). It is hypothesized that rotavirus ssRNAs form 
complexes through cis-acting elements to form a supramolecular complex that engages 
structural proteins of the inner core shell, including VP1, V2, and VP3 (32). These RNA-
RNA interactions are facilitated through conserved sequences within the 5’ and 3’ 
termini, which likely harbor RNA structural elements that act as assortment and 
packaging signals (79, 80). More recently, Borodavka, et al. have demonstrated that 
folding of the ssRNA segments mediated by NSP2 is a major factor in determining 
interactions between specific RNAs (81).  
 
Replication intermediates 
While viroplams and their contents are difficult to observe or purify by traditional 
approaches, subviral particles capable of in vitro genome replication can be isolated via 
biochemical techniques (82). By EM (83), these particles are heterogenous, and are 
thought to represent replication intermediates that demonstrate a stepwise assembly 
process. Small, smooth surfaced particles may be forming viral cores, consisting of viral 
RNAs bound to VP1 and VP3 in assembling VP2 cores. Larger, honeycomb surfaced 
particles may be indicative of assembling cores that have acquired the VP6 intermediate 
layer. Both particle types, however, are very fragile and are sensitive to RNases, 
suggesting they have not fully formed intact, complete capsid layers. Together with 
biochemical studies assessing protein activity and RNA binding affinities, this data 
supports a consensus model of assembly (24, 84). In this model, ssRNAs associate with 
each other, and individually, with a VP1 polymerase and VP3 methyltransferase. VP2 
 
 20 
begins to associate with the complex, and interactions between VP2 and VP1 trigger the 
initiation of replication, synthesis of the minus-strand of the dsRNA genome. Each 
polymerase functions independently, but the process is synchronized between each 
replication unit such that replication of each segment is concurrent with replication of the 
others (85). During this process, the VP2 core shell assembles and acquires the VP6 
intermediate layer to form a DLP.  
 
Virion morphogenesis, maturation 
 To form a fully infectious virion, particles formed during replication must next 
acquire the outer capsid layer. DLPs must exit the viroplasm and bud through the 
endoplasmic reticulum (ER), by a process in which they encounter VP4, NSP4, and VP7. 
VP4 is a cytoplasmic protein, and DLPs associate with this protein en route to the ER. 
NSP4 is associated with the ER membrane, and in binding to VP6, acts as a receptor to 
facilitate movement of the DLP into the ER compartment (86). DLPs bud into the ER, 
and thus they are enveloped, but only briefly; breaching this membrane allows the DLP 
to associate with VP7, an ER-resident glycoprotein, and for full assembly of the VP4-
VP7 capsid layer. It is likely that VP4 spikes form contacts with the VP6 layer first, 
which is then filled in with a continuous layer of VP7 trimers (87). Binding of the outer 
layer is Ca2+ dependent, and NSP4 plays an additional role as a viroporin, facilitating 
release of Ca2+ from intercellular stores (88) by interacting with the Ca2+-sensing protein 
STIM (89). This Ca2+ release facilitates stabilization of the outer capsid layer, but also 
triggers kinase cascades that lead to autophagy (90, 91). Virions are then released from 
cells by lysis (92), or through a budding process that is not immediately lethal to infected 
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cells (93). Following release, virions must encounter trypsin to mature to fully infectious 
particles (94).  
 
Innate immune responses during rotavirus infection 
 Rotavirus infection rapidly triggers broad innate immune responses within 
infected cells, prior to the activation of rotavirus-specific immune cell responses (95). 
Hosts have evolved a number of pattern recognition receptors (PRRs) (Table 1-4, Fig. 1-
4) by which they detect the presence of an invading pathogen and trigger responses that 
lead to induction of interferon and anti-viral interferon stimulated genes (ISGs). 
Regardless of strain, interferon responses appear to be a dominant host response to 
rotavirus infection, particularly in pigs and humans (96, 97). This response is largely 
triggered by the detection of viral RNA that is recognized as non-self during replication 
(98, 99). However, specific activation of innate immune response signaling cascades 
appears to vary by strain and by cell type (100), and the approaches by which rotavirus 
combats these responses also diverges by strain and host species specificity. Viruses may 
evade detection through sequestration of key viral elements, disrupt expression or 
activation of transcription factors required for innate immune response induction, or 
inhibit downstream signaling cascades involved in transduction of amplifying responses 
(101).  
 Interferon induction is triggered by an initial detection of a pathogen associated 
molecular pattern (PAMP) by a dedicated PRR. During RNA virus infections, these can 
include Toll-like receptors (TLRs), nucleotide-oligomerization domain (NOD)-like 




PRR Canonical molecular pattern Putative rotavirus ligand 
TLR2/TLR6 Bacterial lipoprotein None 
TLR4 Bacterial lipopolysaccharide None 
TLR3 dsRNA dsRNA 
TLR7 ssRNA ssRNA 
RIG-I Capped dsRNA Capped dsRNA, hairpin ssRNA 
MDA5 dsRNA dsRNA 
NOD2 Bacterial peptidoglycan None 
PKR dsRNA dsRNA 
 















Figure 1-4. Innate immune responses to RNA virus infection. Upon virus entry, dsRNA 
(purple) is detected by PRRs such as RIG-I or MDA5 in the cytoplasm, or TLR3 in 
endosomes. Cytoplasmic PRRs signal through IPS at the mitochondria to MAVS, which 
results in activation of IKKα and IKKβ (IKK complex). Activated IKK phosphorylates a 
a degron sequence of IkB, the inhibitor of NF-kB, allowing for recognition by B-TrCP 
and subsequent IkB ubiquitination and degradation by the 26S proteasome. NF-kB that 
has been freed of its inhibitor translocates to the nucleus to induce interferon. Similarly, 
TLR3 detection of dsRNA also results in interferon induction. TLR3 interacts with PI3K 
and TRIF, activating IKKi and TBK1, resulting in IRF phosphorylation, dimerization, 











recently, even receptors classically associated with DNA, such as cGAS (cyclic GMP- 
AMP Synthase) (99, 102). These PRRs are expressed in distinct areas of the cell as 
membrane-associated or as cytosolic proteins, resulting in broad surveillance that can 
result in specific activation of individual focused responses. Ultimately, detection of a 
PAMP by an associated PRR can result in interferon expression. Expressed interferon 
binds to receptors on the infected cell, triggering amplified autocrine interferon signaling, 
and to adjacent cells, triggering paracrine responses.    
 Triggering through MAVS (mitochondrial antiviral signaling protein, also known 
as VISA or Cardif) is known to be crucial for innate immune response activation during 
rotavirus infection (103). MAVs signaling is initiated through the activation of RIG-I or 
of MDA-5 (melanoma differentiation-associated protein 5). Both of these PRRs appear to 
be crucial to build an effective response to rotavirus (103, 104). This response is 
dependent on active replication, as no response can be observed upon infection with UV-
inactivated virus (103). This finding suggests that the relevant PAMP during rotavirus 
infection is a product of replication, rather than the entering viral genome contained in 
DLPs (104).  
RLRs sense the presence of rotavirus replication products or intermediates in the 
cytoplasm and recruit MAVS in order to activate cytosolic transcription factors. 
Transcription factors like interferon regulatory factors (IRFs) and nuclear factor-kappa B 
(NF-κB) are promoters of interferon expression and rely on specific kinases in the I-
kappa-B kinase (IKK) complex (IKKα, IKKβ) or the IKK-related kinases (TKB1, IKK-ε) 
for activation. NF-κB and IRF transcription factor families are activated simultaneously 
(105), but they are responsible for activating distinct groups of downstream target genes;  
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most pro-inflammatory cytokines signal through NF-κB, whereas type 1 interferon 
activation relies primarily on IRFs (106-108). Cytoplasmic IRFs are directly activated by 
phosphorylation of their C-termini by TBK1 or IKK-ε (109). This modification leads to 
dimerization of IRFs and their subsequent translocation to the nucleus where interferon 
induction proceeds.  
In contrast to activation of IRFs, where phosphorylation occurs directly on the 
transcription factors themselves, phosphorylation within NF-κB signaling cascades 
occurs instead on a conserved phosphodegron motif of IκB, the inhibitor of NF-κB. Prior 
to PRR signaling induction, NF-κB dimers exist in a sequestered state in the cytoplasm, 
bound to their inhibitors. When upstream signaling has commenced and the IKK complex 
is activated, the IκB phosphodegron motif, DSGIS, is phosphorylated on two serine 
residues by IKKα and IKKβ, the catalytic units of the IKK complex. Dual modification 
of IκB is detected and bound by β-TrCP, an F-Box-containing adaptor protein of cellular 
E3 ubiquitin ligases, leading to subsequent ubiquitination and degradation of IκB. By 
degrading the inhibitory protein, NF-κB transcription factors are free to relocate to the 
nucleus. In addition to IκB phosphorylation, some reports suggest that the p65 subunit of 
NF-κB also undergoes phosphorylation for optimal activity (110).   
 Evidence also supports roles for membrane-associated or endosomal PRRs during 
rotavirus infection (111, 112). Specific preference for detection pathways and associated 
PRRs may be cell-type specific, and the role of TLRs has not been extensively studied. 
TLR7 and TLR9 have been implicated in antiviral signaling in plasmacytoid dendritic 
cells (pDCs), however this cell type is not a primary target of rotavirus infection (113). 
Despite limited permissiveness to rotavirus infection, pDCs contribute a significant 
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interferon response during infection (113). Further research is required to uncover the 
intricacies of interplay between rotavirus specialized immune cells during infection.  
 
Rotavirus proteins with roles in innate immune evasion, antagonism, and activation 
VP3 
 VP3 is an 835 amino acid protein that is the product of genome segment 3. While 
the role of VP3 as a structural protein with methyltransferase activity has been studied 
extensively, VP3 has also been shown to influence virulence in mice and piglets, 
suggesting a role for this protein in host range restriction (114, 115). Capping and 
methylation by VP3 may result in shielding of viral RNAs from host PRRs (116), but for 
reasons that remain unclear, a small percentage of rotavirus RNAs have been found to 
lack these modifications. More recently, VP3 has been shown to directly influence 
signaling through the OAS/RNAse L pathways through a different activity, (117-119). 
VP3 cleaves 2’,5’-oligoadenylates (2-5As) produced by oligoadenylate synthetase 
(OAS), a cytoplasmic dsRNA PRR that activates RNase L to cleave RNAs. The RNase L 
response disrupts viral infection by directly attacking viral and cellular RNAs, but also 
produces ssRNAs to activate other interferon-inducing RLRs. Few structural details are 
available for VP3, but by homology modeling, it bears striking similarities to viral 
enzymes from bluetongue and vaccinia viruses (120).  
 
dsRNA binding protein 
 Some RVC strains encode two separate proteins on genome segment 6: NSP3 and 
a small dsRNA binding protein (dsRBP). The rotavirus dsRBP has predicted homology 
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with dsRBP domains used by many cellular proteins to bind dsRNA, including protein 
kinase R (PKR), an interferon induced protein with pro-apoptotic functions. PKR binds to 
dsRNA through tandem N-terminal dsRNA binding motifs, which facilitates dimerization 
and autophosphorylation reactions, activating the protein. Once active, PKR 
phosphorylates the eukaryotic translation initiation factor eIF2a. This phosphorylation 
inhibits mRNA translation, thus preventing both cellular protein production but also any 
production of viral or pro-viral proteins. By mimicking PKR, the RVC dsRBP sequesters 
viral RNA from PKR binding and activation, or any other accessible PRRs.  
 
NSP3 
 Many RNA viruses harbor the ability to alter the activity of host translational 
machinery such that viral replication and protein production is favored over production of 
host proteins (121). This feature allows viruses a broad approach to bolster their own 
replication systems while also impeding host antiviral responses, including expression of 
interferon and any interferon signaling molecules or stimulated genes that may have 
detrimental outcomes.  
NSP3 is a 313 amino acid protein encoded by genome segment 7, and one of its 
primary functions is to enhance translation of viral mRNAs and impair host translation 
during infection (122). NSP3 forms dimers in infected cells, and the N-terminus of 
dimerized NSP3 has strong affinity for the 3’ consensus sequence of viral ssRNAs (123). 
The C-terminus interacts strongly with eIF4G, a component of the eukaryotic eIF4F cap-
binding complex that aids in recruiting ribosomes to mRNAs. Host mRNAs are poly-
adenylated and bound by poly-A binding protein (PABP) during the initiation of 
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translation; eIF4G bridges PABP and the 5’ cap-binding complex, circularizing RNAs 
during translation initiation. NSP3 mimics the activities of PABP for rotavirus ssRNAs, 
which are not polyadenylated. By binding eIF4G and the 3’ end of rotavirus ssRNAs, 
NSP3 circularizes viral mRNAs, evicts PABP from eIF4G complexes, and aids in 
recruitment of ribosomes. This process sequesters crucial components of translation 
machinery and inactivates PABP, inhibiting translation of host mRNA templates. In line 
with this activity, NSP3 must have a functional RNA binding motif in order to disrupt 
host translation (124). This model however, may be incomplete, as RNAi silencing of 
NSP3 does not inhibit generation of viral proteins or reduce viral yields from infected 
cells (125). Similarly, productive, high-yield mutant viruses exist that encode defective 
NSP3 (126). Interestingly, NSP3 has a long coiled-coil domain that is responsible for 
dimerization of the protein, and also for binding to heat shock protein 90 (HSP90), a 
process that precedes its acquisition of function (127, 128).   
  
NSP4 
 NSP4 is a 175 amino acid protein encoded by genome segment 10. Three 
individual populations of NSP4 are produced during the course of rotavirus infection: 
transmembrane NSP4 in the ER (129), secreted soluble NSP4 (130, 131), and viroplasm 
localized NSP4 (129). In these different cellular compartments, NSP4 plays distinct roles 
during rotavirus infection, including aiding in virion morphogenesis and as the only 
rotavirus protein known to function as an endotoxin. Secreted NSP4 may account for 
early onset diarrhea, or diarrhea in individuals in the absence of any observable 
histopathological changes within the small intestine (132). Expression of NSP4 alone has 
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been shown to induce significant pro-inflammatory cytokine expression from murine 
macrophages and appears to induce signaling through interactions with TLR2 (133). It 
has also been reported that children produce antibodies against NSP4 early in infection or 
upon vaccination (134, 135), but it is unclear what role specifically this interaction may 
play in modulating infection.  
 
NSP1: A key modulator of cellular immune pathways 
NSP1 is encoded by genome segment 5 and remains the best-characterized 
rotavirus innate immune antagonist to date (136). NSP1 proteins from diverse strains 
have been shown to be associated with the degradation of IFN signaling proteins within 
both the IRF and NF-κB signaling cascades (137). Examination of rotavirus species from 
diverse hosts and their innate immune targets has yielded a classification system based 
upon the C-terminal sequences of NSP1 proteins. These viruses fall into three primary 
groups based on this categorization: IRF targeting NSP1s, NF-κB targeting NSP1s, and 
those which fall somewhere between and share features with both previous groups (138) 
(Table 1-5). The C-terminus is a key determinant in host range restriction and in 
determining which innate immune pathway is primarily targeted during infection (138, 
139); motifs within this region of the protein are often termed substrate recognition 
sequences. NSP1 proteins have been reported to interact with numerous cellular proteins, 
including p53 (140), TRAF2 (141), and MAVS (142); however, most evidence suggests 
the proteins have a targeted approach to facilitate β-TrCP or IRF3/IRF7 degradation.  
Despite target diversity and significant sequence variation between strains, evidence 




OSU-like   Porcine  OSU  CTGS-KTVDYDSGISDVE 
   Human WI61  CIEP-KTVDYDSGISDVE  
Human Wa  HTEL-KTAEYDSGISDVE 
   Human DS-1  YEKD-RTAEHDSGISDIE 
UK-like  Bovine  UK  NKRNELIDEYDLELSDVE 
   Human AK-13 NKRNDLMDEYSYELSDTE 
SA11-4F-like Simian SA11-4F KNSGTLTEEFELLISNSEDDNE 
   Simian RRV  EEEGKLSEEYELLISDSEDDD 
   Human B4106 EEEGKLAEEYELLISDSEDDD 
   Lapine 30-96 EEEGRLAEEYELLISDSEDDD 
   Human Ro1845 EEEGKISEEYELLISDSEDDD 
   Canine  K9  EEEGKISEEYELLISDSEDDDQ 
   Equine L338  YEQGELSEEYELLISDSDGDE 
   Equine FI14  EKQGKLSEEYDLLISDSDDD 
   Murine ETD  QEHGDLAEEFDLLLSSSDSDED 
  
Table 1-5. NSP1 C-terminal alignment, grouped into OSU-like β-TrCP targeting strains, 
SA11-4F-like IRF-targeting NSP1s, and UK-like NSP1 proteins that share features and 















(138), supporting the hypothesis that common mechanisms may be utilized in their 
activities. Full-length NSP1 localizes throughout the cytoplasm in a punctate manner, and  
NSP1-induced degradation of targets has been shown to be dependent on proteasome 
activity (136-138, 143). As a result of these findings, NSP1 has been hypothesized to 
modulate and redirect components of the cellular ubiquitin-proteasome pathway to 
facilitate degradation of cellular targets within antiviral immune signaling pathways (138, 
144, 145). 
The prediction of a putative RING domain within the N-termini of NSP1 proteins 
(146) initially supported the hypothesis that NSP1 proteins functioned as viral-encoded, 
single protein E3 ubiquitin ligases (138). Functional E3 ligases must interact with an E2 
ubiquitin-conjugating enzyme in order to facilitate transfer of an ubiquitin moiety to their 
targets; this interaction is facilitated through a RING domain. However, direct evidence 
supporting NSP1-facilitated poly-ubiquitination of known targets in the absence of 
cellular machinery is currently insufficient. It is possible for a small protein to act singly 
as an E3, such as the cellular TRIM family of proteins (147), however, given the known 
role of the C-terminal 10-20 amino acids of NSP1 in conferring substrate specificity, this 
hypothesis seems unlikely. Furthermore, new data supports a model in which NSP1 
interacts directly with Cullin3 scaffold proteins of cullin-RING E3 ubiquitin ligases 
(CRLs) (144, 145, 148). 
Because of the abundance of cellular CRLs and their adaptable nature, it is hardly 
novel that viruses may adopt strategies to inhibit or redirect CRLs to their own 
advantage. Other viral proteins (Epstein-Barr virus LMP1, HIV-1 Vpu, vaccinia virus 
A49) (149-151) are known to utilize mimicry to interact with β-TrCP and inhibit NF-κB 
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interferon signaling without facilitating the degradation of cellular E3 ligase machinery. 
Notably, Vpu directly appropriates the E3 ubiquitin ligase activity of SCFβ-TrCP to target 
host proteins for proteasomal degradation (152). To this end, Vpu behaves as an added 
adaptor protein to shift targeting from IκB to instead include CD4 and tetherin as 
ubiquitination substrates. Recently, HBV X protein, too, was reported to hijack a cellular 
CRL; to direct degradation of Smc5/6, X protein acts as an adaptor to shift targeting 
towards cellular substrates (153).  
Like Vpu, NSP1 recruits the F-box protein β-TrCP, disrupting NF-κB signaling 
and preventing interferon expression (138). However, the precise mechanism of NSP1 
activity has remained controversial, particularly with respect to proposed ubiquitination 
and degradation of targets. Recently, three studies identified a novel role for NSP1 as an 
adaptor protein of a modified, hijacked CRL, similar to the mechanism employed by Vpu 
or X protein. The indication that NSP1 fosters a direct, functional interaction with the 
amino-terminus of CUL3 (144, 145) suggests an added role for NSP1 in the repurposing 
of cellular degradation machinery to favor viral replication and survival. 
NSP1 proteins from OSU and Wa strains, both specific β-TrCP targeting 
antagonists, associate directly with cullins, and with components of assembled CRLs, 
including Rbx1 and Nedd8 activating proteins (144, 145). Furthermore, NSP1-induced 
innate immune antagonism and degradation of substrates does not occur when the 
association of these components (CUL3, Rbx1) is impeded chemically or through 
mutagenesis (144). This reliance on the functioning of components within CRL 
complexes represents the first evidence to directly dispute the hypothesis that NSP1 may 
act on its own as a single-polypeptide E3 ligase. Moreover, this finding can be expanded 
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and applied to the IRF-targeting NSP1 proteins, fostering a uniting link between classes 
of NSP1 antagonists (145). That NSP1 appears to interact with multiple cullin types 
remains especially intriguing, and as suggested by Lutz, et al., NSP1 may be using cullin-
containing complexes to interfere with an as yet unidentified cellular process. 
Furthermore, NSP1 may only require a small number of repurposed CRLs in order to 
effectively inhibit innate immune signaling (145). Lutz, et al. posit that neither dominant 
negative use nor siRNA knockdown of either Cul1 or Cul3 interrupted NSP1-mediated 
degradation of targets, suggesting that the small proportion of the cytoplasmic cullin 
population remaining unaffected is sufficient for NSP1 to exert control over IFN 
signaling pathways. Ding, et al. instead support that cullins are a necessity for NSP1 
innate immune antagonism to occur. It may also be possible that binding alone is 




Research program overview 
Hypothesis 
 To extend our understanding of the functional role of NSP1 in rotavirus infection 
and its contribution to control of innate immune responses, the following hypothesis was 
proposed:  
 Human and porcine NSP1 proteins are known to interact with β-TrCP through a 
conserved C-terminal motif. We propose that this region of the protein, a mimic of the 
phosphodegron of IκB, is phosphorylated by a cellular kinase and that phosphorylation is 
an activating event that regulates NSP1 activity. We propose to evaluate the 
phosphorylation status of NSP1, to identify cellular kinase(s) responsible for the 
modification, to examine the role that phosphorylation plays in NSP1 control of cellular 
CRLs, and to assess how phosphorylation regulates NSP1 control of host responses to 
infection.  
 
Summary of experimental aims and approaches 
Specific Aim 1: To determine the phosphorylation status of the C-terminal NSP1 
IκB-like motif. Utilizing phospho-specific antibodies generated against the 
phosphorylated IκB degron, we will assess the phosphorylation status of NSP1 by 
immunoblot. We will probe the cross reactivity of this antibody by incorporating mutant 
NSP1 proteins, and validate our findings with the incorporation of protein phosphatase 
treatment.  
Specific Aim 2: To determine the identity of cellular kinases responsible for 
NSP1 phosphorylation. By in silico analysis, we will assess the surrounding degron 
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context within the NSP1 C-terminus to identify consensus sequences of cellular kinases. 
We will validate or dismiss hits through directed mutagenesis of kinase priming motifs, 
the use of kinase specific small molecule inhibitors, and RNAi.  
Specific Aim 3: To assess the role of phosphorylation in regulation of NSP1 
activity. By immunoprecipitation assay, we will address NSP1 binding to both targets and 
CRL machinery, for wildtype NSP1 and phospho-deficient NSP1 proteins.   
Specific Aim 4: To characterize the ability of NSP1 to antagonize cellular 
responses to infection, and how this response is affected by NSP1 phosphorylation status. 
In addition to NF-κB signaling and interferon induction, β-TrCP regulates numerous 
pathways. We will address the effect of phosphorylated NSP1 on signaling through these 
cascades, with particular emphasis on mTOR and pro-apoptotic signaling.  
 
Significance of study 
To date, there has been remarkably little data to support the notion that NSP1 
proteins from various strains utilize common mechanisms to target host innate immune 
pathways. However the development of new technologies, including the use of sequence-
searching motif databases, has uncovered previously unknown similarities between NSP1 
proteins of diverse strains to support this hypothesis. While primary sequence varies 
significantly between strains, and even within classes of NSP1 proteins, new data 
suggests the retention of similar predicted structures, as well as a common role for the C-
terminal motifs of these proteins, much like what has been described for the OSU NSP1 
phosphodegron. Descriptions of the precise requirements of NSP1 antagonistic 
mechanisms describe a role for NSP1 as a novel adaptor protein of CRL3 complexes, and 
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these new data elaborate on exciting interactions between NSP1s and host ubiquitination 
machinery.  
 In this thesis, NSP1 has been classified as a novel substrate adaptor protein of 
cellular E3 ubiquitin ligases, particularly those incorporating a Cullin 3 scaffold. This 
finding is built upon studies integrating assessment of protein-protein interactions and 
biochemical analysis of both exogenously expressed protein and for viral proteins 
produced during the course of infection. Also included are assessment of both up- and 
down-stream effects and effectors of these interactions and protein modifications. An 
activating modification of NSP1 has been identified as a crucial, integral event that 
precedes antagonistic activity of the protein: NSP1 must be phosphorylated on a 
conserved, IκB-like motif within the C-terminus, and this modification is mediated by the 
cellular kinase CKII. To our knowledge, no other known kinases are able to fulfill this 
role in the absence of CKII activity or expression. Analogous modifications are observed 
for numerous NSP1 proteins that contain similar motifs, and data suggests that this 
activating event occurs regardless of host species. Following phosphorylation, NSP1 is 
able to bridge interactions with its primary target, β-TrCP, acting as a mimic of the IκB 
degron. This initial interaction is likely the limiting step in hijacking of Cullin-RING 
ligases; phosphorylation precedes interaction with targets, but also precedes any 
integration of NSP1 proteins into commandeered cellular ligases. Interestingly, while 
recruitment of β-TrCP into hijacked Cullin-RING ligases leads to ubiquitination and 
degradation, the activity of β-TrCP appears to be inhibited prior to the terminal steps of 
this pathway. This finding suggests that interaction alone is sufficient to inhibit activity, 
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an activity with significant effects on interferon induction pathways, as well as other 
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Viruses commandeer the use of cellular machinery to support their replication and 
to down-regulate antiviral host pathways. Recent studies continue to highlight the 
importance of the ubiquitin proteasome system in viral replication processes, and in 
particular, highlight enzymes of the cullin-RING E3 ubiquitin ligase (CRL) family. CRLs 
facilitate a critical step in the ubiquitination process, in which substrate proteins are 
modified with the addition of small ubiquitin moiety tags. Ubiquitin tags affect target 
proteins by altering protein activity or localization, or by inducing protein turnover via 
proteasomal degradation. Pathogens interact with CRL machinery by a number of 
complex approaches, and many viruses encode proteins that incorporate into CRLs by 
acting as substrate adaptor proteins. Viral adaptor proteins shift the specificity of CRL 
machinery resulting in ubiquitination of novel targets, including host antiviral factors. 
This review describes the organization and function of CRLs, mechanisms of viral CRL 
adaptor proteins, and the types of host proteins targeted by hijacked CRLs.  
 
Introduction 
As obligate intracellular parasites, viruses seize control of existing cellular 
machinery to support their replication. Co-opted or repurposed host proteins perform 
numerous essential roles during viral replication, including aiding in adsorption and entry 
(154), expression of viral proteins (155), and antagonism of antiviral immune responses 
(156). Such hijacking of host proteins benefits viral replication by promoting a cellular 
environment that is favorable to specific aspects of the viral lifecycle. For example, 
maintenance of a pro-viral cellular environment often requires the degradation of cellular 
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proteins that have antiviral activity. This degradation is of particular importance in 
suppressing interferon (IFN) expression within infected cells (156). To this end, the 
ubiquitin proteasome system (UPS), a key regulator of protein degradation and recycling, 
has been identified as a common target for viral hijacking.  
The UPS is a degradation pathway integral to the regulation of many normal 
cellular processes, including cell growth and cell cycle regulation, DNA damage repair, 
and response to infection or other stressors (157). The UPS utilizes ubiquitin, a small 76 
amino acid polypeptide, to target substrates at accessible lysine residues via covalent 
peptide linkages. The addition of a single ubiquitin tag alters cellular function or 
localization, whereas Lysine-48 linked poly-ubiquitin chains (158) mark substrates for 
proteasomal degradation (159). Ubiquitination is an ATP-dependent process and requires 
the involvement of three distinct classes of enzymes (160), including a ubiquitin-
activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a target-specific 
ubiquitin ligase (E3). E1 enzymes catalyze the first step of the process by binding free 
ubiquitin. E1 enzymes transfer ubiquitin proteins to E2 enzymes, which associate with E3 
ubiquitin ligases. E3 ubiquitin ligases are responsible for conferring specificity of 
substrate proteins, and by bridging bound substrates and ubiquitin-charged E2 enzymes, 
facilitate transfer of ubiquitin moieties from E2 to substrate (Figure 1). Humans have two 
E1 proteins and approximately 40 known E2 enzymes, but hundreds of E3 ubiquitin 
ligases exist and specify thousands of targets with a great degree of selectivity.  
Some E3 ubiquitin ligases function as large modular complexes of several 
subunits whereas others are single-protein enzymes (147). Distinct families can be 
characterized by conserved structural motifs or the mechanism by which ubiquitin is 
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transferred from E2 to target. The vast majority of E3 ubiquitin ligases include a RING 
(really-interesting-new-gene) domain in their construction that mediates interactions with 
ubiquitin-charged E2s (161, 162). Classic RING domains consist of a conserved zinc-
binding Cys3-His-Cys4 motif; however, variations of this motif exist and can also include 
Cys3-His2-Cys4 and Cys4-His-Cys3 domains (157), among others.  
 
Cullin-RING E3 ubiquitin ligase construction and regulation 
Cullin-RING ligases (CRLs) comprise the most populous group of E3 ubiquitin 
ligases. CRLs function as large multi-subunit assemblages and are the paradigms for 
modular ubiquitin ligase construction (163, 164). CRLs are minimally comprised of a 
cullin scaffold protein (Cul1, 2, 3, 4a, 4b, 5, or 7) with a RING-box protein subunit 
(Rbx1, Rbx2) at the cullin C-terminus, and at the cullin N-terminus, an adaptor complex 
of one or two proteins, sometimes including a bridging protein and a substrate adaptor 
protein (an F-box protein). Archetypal CRLs are built on a Cul1 scaffold, and are known 
as S phase kinase-associated protein 1 (SKP1)–cullin 1 (Cul1)–F-box protein (SCF) 
complexes (Fig. 2-1). Substrate specificity of SCFs is primarily determined through the 
F-box proteins or by additional adaptor proteins that bind a variable region of the F-box 
protein (165). There are approximately 70 known cellular F-box proteins that can 
interchangeably bind the SKP1 bridging subunit on SCFs, conferring an enormous degree 
of flexibility in the selection and targeting of substrates (160). Cul2-, Cul3-, and Cul5-
containing CRLs (CRL2s, CRL3s, CRL5s) also incorporate a diverse range of substrate 





Figure 2-1. The SCFβ-TrCP ligase targets many cellular proteins to control a myriad of 
cellular processes. The SCFβ-TrCP ligase is a CRL1, and contains a Cullin 1 scaffold 
protein that bridges Rbx1 and ubiquitin-charged E2 enzymes at its C-terminus, and 
adaptor proteins Skp1 and β-TrCP at its N-terminus. β-TrCP binds target proteins that 
contain a phosphodegron sequence that can be activated cellular kinases. Through 
neddylation, the addition of a Nedd8 moiety to the cullin scaffold, ubiquitin is transferred 
from the E2 enzyme to the target protein, leading to modification and degradation of the 
target. Many β-TrCP targets exist, and their turnover is directly regulated by activation of 
the phosphodegron sequence .The phosphodegron sequence of IκB (SGLDS), a key 
regulator of NF-kB and interferon signaling, is modified by IKK. mTOR and CKI 
activate the DEPTOR phosphodegron (SGYFS). DEPTOR is a component of mTORC1 
and mTORC2, and as a regulator of both complexes, control autophagy and apoptosis. 
Similarly, the PDCD4 phosphodegron (SGRGDS) is activated by P13K, and turnover of 
this protein effects protein translation mediated by eIF4A/G. IFNAR1 contains a 





























































utilize BTB (broad complex, tramtrack, bric-a-brac fold) (166) whereas CRL2s and 
CRL5s incorporate VHL-box bridging proteins with an Elongin B/C adaptor (167).  
Flexibility is integral to the plasticity of the UPS and its ability to rapidly gain 
control of complex processes, such as cellular homeostasis and cell cycle functioning 
(168). Despite CRL diversity in both structure and composition, conserved mechanisms 
regulate their specificity and activity. Modular construction coupled with dynamic 
assembly and disassembly enables one core E3 complex to ubiquitinate numerous 
individual substrates through successive cycling (164). Exchange of CRL subunits is 
subject to various levels of regulation, including processes that affect covalent attachment 
of assembly factors, such as Nedd8, in a process known as neddylation (169). 
Neddylation promotes the activity of CRLs, and involves cyclic attachment of a Nedd8 
modification to trigger conformational changes within the Cul scaffold protein. This 
process closes a 50 Å gap between the ubiquitin-charged E2 and bound substrate, 
catalyzing ubiquitin transfer (170, 171). Conversely, Nedd8 removal, regulated by the 
COP9 Signalosome (CSN), acts as a signal for SCF complex dissociation and recycling 
(172, 173). In the absence of substrates, unneddylated cullins can exchange substrate 
adaptor proteins through the activity of cullin-associated and neddylation dissociated 1 
(Cand1), an exchange factor for adaptor proteins that biases assembly towards adaptors 
for which substrates are available (174). CRLs do not intrinsically have catalytic activity, 
but catalyze ubiquitination by increasing the local concentration of reactants and 





CRLs as targets of viral manipulation 
Taken together, the flexibility of CRL regulation, combined with versatility in 
construction and final composition, makes these complexes viable targets for viral 
manipulation. Their sensitivity to the availability and concentration of reactants makes 
them easily exploited by pathogens; data supports that these structures are hijacked and 
repurposed by viral proteins that interfere with normal targeting at varying levels (176). 
Some viral proteins act by obstructing binding faces [e.g. SV40 LTag (177), polerovirus 
P0 (178)] or sequestering crucial modular units of CRLs [e.g. vaccinia virus A49 (151), 
Epstein Barr virus LMP1 (149)], to halt complex assembly. Other viruses encode proteins 
that function as substrate adaptor proteins (rotavirus NSP1, HIV Vpu; see below); like 
their cellular counterparts, these viral proteins bind on one end to a substrate to be 
targeted for proteasomal degradation, and bind on an opposing face to the remainder of 
the CRL assemblage. By taking the place of a cellular substrate adaptor protein or by 
binding to an existing adaptor as a secondary adaptor, these proteins redirect the targeting 
activity of CRLs (Fig. 2-2). This tactic can be particularly instrumental in modulating 
innate immune responses by targeting signaling molecules necessary for IFN expression. 
Hijacking of this system by viral proteins serves a myriad of additional roles, some of 
which we will describe below. 
 
Suppression of IFN signaling  (Rotavirus, RVFV) 
Viral-E3 interplay can be illustrated by our understanding of the innate immune 
antagonist protein of rotavirus, NSP1, and its interactions with CRL3s. This protein 




Figure 2-2. Schematic depiction of CRLs with viral adaptor proteins. In each image, 
cullin scaffold proteins are shown in orange, Rbx proteins are shown in periwinkle, E2 
enzymes are shown in goldenrod, and ubiquitin moieties are depicted in turquoise. 
Cellular adaptor components are shown in light green, viral proteins are red, and target 
proteins are light yellow. (A) HIV-1 Vpu, shown assembled with CRL1, targets CD4 and 
tetherin for ubiquitination. (B) HIV-1 Vif assembles with CRL5, and binds EloB/C and 
CBF-β to target A3F and A3G for ubiquitination. (C) HIV-1 Vpr binds DCAF1 and 
DDB1 proteins in a CRL4A to target UNG2. (D) Like Vpr, SIV Vpx assembles on a 
CRL4A, but instead targets SAMHD1 for ubiquitination. (E) RVF virus NSs binds β-
TrCP adaptor proteins, which together with Skp1, bind a CRL1. NSs binds PKR proteins 
as substrates. (F) RSV NS1 assembles with a CRL2 and binds the EloB/C components. 
NS1 targets STAT2 for ubiquitination, but does not directly bind this target protein and 
likely requires an additional protein adaptor. (G) SV5 V binds DCAF1 and DDB1 
proteins of both CRL4A and CRL4B to target STAT1 for degradation. (H) HBV HBx 
binds DDB1, displacing DCAF1, to direct CRL4A and CRL4B to facilitate ubiquitination 
of Smc5/6. (I) Rotavirus NSP1 assembles directly on the Cul3 scaffold of CRL3 without 
any known cellular adaptor proteins. NSP1 proteins direct degradation of β-TrCP, IRF3, 
and IRF7. (J) VACV A49 binds the β-TrCP adaptor component of CRL1 and sequesters 
the complex in an inactive state. (K) EBV BZLF1 EBV BZLF1 binds the EloB/C 
component of CRL2 to specify p53 as a ubiquitination target. (L) HPV16 E7 assembles 
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repeat-containing protein (β-TrCP) for degradation, the substrate adaptor component of 
cellular SCFβ-TrCP (137, 143) (148). β-TrCP is a necessary component of the NF-κB 
signaling cascade and is crucial for the induction of IFNs and IFN-stimulated genes 
(ISGs), leading to an antiviral state in affected cells (179). In an uninfected cell, the 
inhibitor of kappa B (IκB) is bound to NF-κB transcription factors, sequestering them in 
an inactive state in the cytoplasm. Sensing of double-stranded RNA (dsRNA) by retinoic 
acid-inducible gene 1 (RIG-I)-like receptors, or other pathogen associated molecular 
signatures, induces signals that activate the IκB kinase complex (IKK) (180). This kinase 
complex phosphorylates a conserved degron motif on IκB, enabling its targeting by the 
SCFβ-TrCP E3 ubiquitin ligase. This interaction facilitates the ubiquitination of IκB and its 
subsequent proteasomal degradation, freeing NF-κB (181) to translocate to the nucleus 
and stimulate induction of IFN (182). By mimicking the IκB degron, NSP1 selectively 
recruits β-TrCP, disrupting NF-κB signaling (138, 148) (Fig. 2-3). As a substrate adaptor, 
NSP1 then recruits the remainder of the CRL3 assembly to facilitate ubiquitination and 
proteasomal degradation of its β-TrCP target. The mechanism employed by rotavirus 
NSP1 is particularly intriguing because this activity involves two distinct cellular CRLs. 
NSP1 disrupts the activity of the Cul1 CRL SCFβ-TrCP by sequestering its substrate-
binding adaptor component (148), and utilizes hijacked CRLs of a different family 
(CRL3s) that to direct the degradation of the SCF component, β-TrCP (144, 145). 
Notably, NSP1 appears to take the place of a two-protein BTB-F-Box protein complex 
typically bound to the N-terminus of Cul3.  
The NSP1 proteins of most human and porcine rotavirus strains target their 




Figure 2-3. A model of NSP1 CRL incorporation. Upon expression, NSP1 is bound by 
the cellular kinase CKII, which facilitates phosphorylation of serine residues within the 
NSP1 C-terminal phosphodegron. Phosphorylated NSP1 is bound by β-TrCP, forming an 
adaptor-substrate complex. Binding of NSP1 to CUL3 facilitates release of CKII and 
incorporation of a ubiquitin-charged E2 enzyme, resulting in a large CRL complex that 
includes β-TrCP, NSP1, Cul3, Rbx1, and an E2. Neddylation of the Cul3 scaffold 
triggers ubiquitin transfer from the E2 to the β-TrCP substrate. Through subsequent 
rounds of assembly and disassembly, NSP1-hijacked CRLs facilitate poly-ubiquitination 















































target other innate immune signaling proteins, such as the IFN regulatory proteins (IRFs) 
(137). Like human and porcine NSP1 proteins, expression of animal NSP1 proteins 
induces the degradation of target proteins in a proteasome- and Cul3-dependent manner 
(144, 145). IRFs and β-TrCP represent vital targets of rotavirus innate immune 
antagonism. Similarly, viruses of other families also require degradation of components 
of the IFN response network for propagation. Like rotavirus, Rift Valley fever virus 
(RVFV) encodes the nonstructural protein NSs which directly associates with β-TrCP 
(183). NSs does not contain a phosphodegron motif, and so likely interacts with β-TrCP 
through an alternate mechanism as a secondary adaptor. This interaction shifts the 
targeting of SCFβ-TrCP to facilitate degradation of protein kinase R (PKR), a viral dsRNA 
sensor that triggers IFN responses. Influenza A virus (IAV) targets IFN signaling 
pathways by inducing ubiquitination and proteasomal degradation of Type I IFN receptor 
1 through actions of the hemaglutinin protein (184), but the precise mechanism or role of 
a CRL has not yet been fully explored.  
 
Immune cell evasion (HIV) 
At least four proteins encoded by human immunodeficiency virus (HIV) are 
known to interact with host CRL assemblies to support viral replication. Among these 
proteins, Vpu supports HIV replication by facilitating evasion of immune cells to protect 
infected cells from NK-mediated death (185). Like rotavirus NSP1, HIV-1 Vpu binds β-
TrCP through a phosphorylated degon-like motif (Fig. 2-2), but like RVFV NSs, Vpu 
functions as a secondary adaptor protein. Both NSs and Vpu-driven complexes utilize the 
natural β-TrCP CRL complex, SCFβ-TrCP. Vpu binding to β-TrCP shifts affinity of SCFβ-
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TrCP to target ICAM-1 surface marker proteins for ubiquitination and subsequent 
degradation (186). During HIV infection, increased intercellular adhesion molecule 1 
(ICAM-1) surface expression on infected cells aids in NK cell targeting of infected cells. 
By reducing surface levels of ICAM-1, HIV prevents NK cell-mediated cell death, 
maintaining cellular support of viral replication and virion generation. It has been shown 
that incorporation of ICAM-1 into progeny virions can increase particle infectivity, and 
Vpu-induced reduction of this protein to protect infected cells may represent an 
evolutionary compromise that results in reduced virus infectivity.  
Vpu adaptor proteins are also able to induce the CRL-dependent degradation of 
the surface receptor CD4. CD4 is required for infection of T-cells by HIV, a process that 
prevents superinfection, and by inhibiting gp120-CD4 binding prior to assembly within 
cells and at the plasma membrane, also promotes particle release (187, 188). Decreased 
CD4-surface expression likely also weakens antiviral innate immune responses (189). 
CD4 interacts with major histocompatibility complex class II on antigen presenting cells, 
and is an important stimulatory factor of receptor-mediated T-cell activation (190). It has 
been reported that CD4 surface expression interferes with particle infectivity, and that 
nascent particles from CD4-negative cells are more infectious than those produced from 
CD4-expressing cells (191). Thus, targeting of CD4 increases longevity of infected cells 







Increased infectivity of nascent particles (HIV, IAV) 
Some viruses are known to package host proteins during budding and assembly 
processes. Incorporation of host proteins into nascent particles can serve pro-viral 
purposes to support subsequent rounds of infection, or conversely, antiviral proteins can 
be packaged as a result of host defense mechanisms. Proteins in the APOBEC family of 
enzymes (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3) are 
cytidine deaminases whose activity catalyzes hypermutation of viral genomes, blocking 
viral spread by inducing lethal mutations. When HIV-1 lacks a functional viral infectivity 
factor (Vif) protein, APOBEC proteins A3G and A3F are packaged into virions, resulting 
in lethal editing of viral cDNA in subsequent rounds of infection. To combat this host 
defense mechanism, the Vif protein recruits Cul5 CRLs as a substrate adaptor protein. 
Vif directly binds CBF-β proteins (192) and Elongin B/C adaptor proteins (193), enabling 
hijacked CRL5s to facilitate targeting of A3F and A3G for degradation (194). Hijacking 
of the CRL system thereby protects the functional integrity of newly formed particles and 
the propagation of HIV infection.   
IAV also utilizes host ubiquitination machinery to promote infectivity of nascent 
particles. IAV ribonucleoproteins are ubiquitinated during the course of infection, 
resulting in enhanced polymerase activity, and it has been shown, that the host 
proteasome is required for IAV virus polymerase function (195). While the E3 ubiquitin 
ligase activity of Nedd4 and Itch play roles in modulating viral entry and release from the 
endosome (196, 197), a process that also requires Cul3 (198), the E3 ubiquitin ligase 




Replication and transcription (HIV, SIV, Hepatitis B) 
CRL4s play significant roles in DNA damage control and cancer, and as such, 
viral proteins that hijack these CRL complexes often do so to support replication and 
protection of viral genomes. Vpr proteins of HIV-1 and HIV-2, as well as the SIV 
proteins Vpr and Vpx all act by recruiting CRL4s. Vpr likely plays a role in nucleic acid 
integrity, as its preferred CRL4 complexes (with a Cul4A scaffold) function in UV-DNA 
damage recognition. Vpr expression halts cell cycle progression in G2 (199), a DNA 
damage checkpoint, and Vpr binding to CRL4s directs degradation of cellular substrates, 
including minichromosome maintenance complex component 10 (MCM10), a known 
target of cellular CRL4s (200). Vpr also bridges interactions between the Cul4A CRL 
complex and UNG2 and SMUG1 uracil DNA glycosylases (201). Like Vpu, Vpr binds 
an existing substrate adaptor protein as a secondary adaptor to redirect CRL specificity. 
To attract UNG2, Vpr utilizes a variable loop for molecular mimicry of DNA, and 
engages the adaptor protein DCAF1 to recruit an active CRL4 (202). The Vpx protein of 
HIV-2 and SIV, however, facilitates the degradation of SAMHD1, a nuclear 
deoxynucleoside triphosphohydrolase (203). SAMHD1 is an antiviral factor that restricts 
HIV replication by depleting intracellular deoxynucleotides below levels that can be 
utilized by the viral reverse transcriptase. Cul4A and Cul4B differ in intracellular 
distribution and in structure, but are interchangeable for Vpr and Vpx activity (204). Vpx 
requires both Cul4A an Cul4B for degradation of SAMHD1 in primary macrophages, 




Recently, the X protein of Hepatitis B Virus (HBx), whose primary role is to 
promote transcription of the viral genome, was reported to hijack a CRL4 (153) The 
Hepatitis B genome exists as an extrachromosomal DNA circle in infected cells, and HBx 
expression enhances transcription from these extrachromosomal DNA templates 
exclusively. To this end, HBx hijacks CRL4s as an adaptor protein to facilitate the 
degradation of the structural maintenance of chromosomes (Smc) complex Smc5/6. 
Smc5/6 has roles in cell cycle progression and recombinational DNA repair, and was 
found to bind episomal DNA templates and to the Hepatitis B Virus genome. This 
binding is an inhibitory sequestration step that prevents viral replication, and by 
facilitating its ubiquitination and proteasomal degradation, HBx supports Hepatitis B 
genome replication by allowing productive gene transcription. 
 
Perspectives and conclusion 
CRLs are responsible for facilitating up to 20% of routine proteasomal 
degradation (205). These complexes are capable of targeting substrates with marked 
specificity to regulate numerous processes within cells. Flexibility of this system largely 
hinges on exchange of substrate adaptor proteins that bind to the N-terminus of cullin 
scaffold proteins or their bridging proteins in order to specify individual substrates. Viral 
proteins are known to interact with CRL machinery in a variety of ways, as more 
extensively described by Mahon et al (176), and many viruses have adopted strategies to 
redirect CRLs by encoding their own CRL adaptor proteins. 
While direct CRL interactions can be described in vitro, we lack a thorough 
understanding of how CRL complexes are regulated in vivo. Many studies suggest that 
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proximity and local concentration are driving factors in regulation, consistent with a 
model that is rapidly adaptive to subtle changes in the intercellular milieu but difficult to 
replicate in vitro. In line with this hypothesis, in vitro data suggests that cullin scaffold 
proteins can be neddylated at a variety of assembly steps, rather than as a final activation 
step. Similarly, Cand1 appears to regulate CRLs in vitro with diverse affects on function 
(206-208), and CRLs are reported to retain their activity in vitro even without 
neddylation (209-211). These results may also suggest that diverse CRLs with varied 
composition are subject to different levels of regulation. For example, a recent study 
(148) identified an ordered sequence of events required for integration of rotavirus NSP1 
adaptor proteins into hijacked CRL3s in a process highly reliant on phosphorylation 
steps; not all adaptor proteins are known to require phosphorylation to engage substrates, 
even when comparing NSP1 proteins from diverse rotavirus strains (212). 
 Within the last decade, research into mechanisms employed by HIV proteins has 
made this group of viral proteins archetypal in control and hijacking of CRLs. In 
particular, the diverse mechanisms employed by Vpu make this protein a model for viral 
control of host responses (213). Vpu is reported to facilitate degradation or down-
regulation of ICAM-1, ICAM-3, BST2/tetherin, CD4, HLA-C, and many others (214, 
215). This list of targets has grown dramatically in recent years, and our understanding of 
the mechanisms through which Vpu exerts this control has diversified. The multi-pronged 
approaches utilized by a single protein, and better understanding of the balance Vpu must 
employ in execution, makes this protein a seminal model for our understanding of other 
viral proteins. Rotavirus NSP1, for example, appears both to require Cul3 scaffold 
proteins for its activity (144, 148), and to perform its antagonistic control of innate 
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immune responses in the absence of this protein (145). As we continue to uncover 
mechanisms employed by these viral proteins and others, and as the range of described 
mechanisms continues to grow, the multi-faceted approach of Vpu may be revealed as a 
widely employed tool set. NSs of Rift Valley may employ similar tactics, as this protein 
is known to interact with at least two distinct F-box proteins to direct degradation of 
distinct cellular targets (183, 216). Furthermore, an increasing numbers of viral proteins 
are reported to immunoprecipitate or directly interact with proteins from this family [e.g. 
Rice black streaked dwarf virus P7-2 (217), human T-cell leukemia virus type 1 bZIP 
(218), adenovirus E40rf6 (219)]. It will be no surprise if many more viral proteins 
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 The rotavirus nonstructural protein NSP1 repurposes cullin-RING E3 ubiquitin 
ligases (CRLs) to antagonize innate immune responses. By functioning as substrate 
adaptors of hijacked CRLs, NSP1 causes ubiquitination and proteasomal degradation of 
host proteins essential for expression of interferon (IFN) and IFN-stimulated gene 
products. The target of most human and porcine rotaviruses is β-TrCP, a regulator of NF-
κB activation. β-TrCP recognizes a phosphorylated degron (DSGΦXS) present in 
inhibitor of NF-κB (IκB); phosphorylation of the IκB degron is mediated by IκB kinase 
(IKK). Because NSP1 contains a C-terminal IκB-like degron (ILD) (DSGXS) that 
recruits β-TrCP, we investigated whether the NSP1 ILD is similarly activated by 
phosphorylation and whether this modification is required to trigger the incorporation of 
NSP1 into CRLs. By mutagenesis and phosphatase treatment, we found that both serine 
residues of the NSP1 ILD are phosphorylated, a pattern mimicking phosphorylation of 
IκB. A three-pronged approach using small molecule inhibitors, siRNAs, and 
mutagenesis assays demonstrated that NSP1 phosphorylation was mediated by the 
constitutively active casein kinase II (CKII), rather than IKK. By co-immunoprecipitation 
assays, we found that this modification was essential for NSP1 recruitment of β-TrCP 
and induced changes involving the NSP1 N-terminal RING motif that allowed formation 
of Cul3-NSP1 complexes.  Taken together, our results indicate a highly regulated 
stepwise process in the formation of NSP1 Cul3-CRLs that is initiated by CKII-
phosphorylation of NSP1, followed by NSP1-recruitment of β-TrCP, and ending with 
incorporation of the NSP1-β-TrCP complex into the CRL via interactions dependent on 




 Rotavirus is a segmented double-stranded RNA virus that causes severe diarrhea 
in young children. A primary mechanism used by the virus to inhibit host innate immune 
responses is to hijack cellular cullin-RING E3 ubiquitin ligases (CRLs), redirecting their 
targeting activity to the degradation of cellular proteins crucial for interferon expression. 
This task is accomplished through the rotavirus nonstructural protein NSP1, which 
incorporates itself into a CRL and serves as a substrate recognition subunit. The substrate 
recognized by NSP1 of many human and porcine rotaviruses is β-TrCP, a protein that 
regulates the transcription factor NF-kB. In this study, we show that formation of NSP1 
CRLs is a highly regulated stepwise process initiated by CKII-phosphorylation of the β-
TrCP recognition motif in NSP1. This modification triggers recruitment of the β-TrCP 
substrate and induces subsequent changes in a highly conserved NSP1 RING domain that 
allow anchoring of the NSP1-β-TrCP complex to a cullin scaffold. 
Key words. Rotavirus, NSP1, β-TrCP, CKII, viral E3 ubiquitin ligase 
 
Introduction  
Rotaviruses, members of the family Reoviridae, are a leading cause of severe life-
threatening diarrhea in infants and children under five years of age (136), (134). The 
segmented double-stranded RNA of these viruses encode six structural (VP1-VP4, VP6-
VP7) and six nonstructural (NSP1-NSP6) proteins (134). Rotaviruses antagonize the 
expression of interferon (IFN) and IFN-stimulated gene (ISG) products chiefly through 
the action of NSP1, the sole protein product of viral genome segment (gene) 5 (115). 
NSP1 is the least conserved of the twelve rotavirus proteins, including VP4 and VP7, the 
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outer capsid proteins of the virus under immunological pressure (137).  However, the 
NSP1 proteins of group A rotaviruses (the subject of this article) have a similar predicted 
secondary structure and share the same N-terminal RING domain motif (137). The C-
termini of NSP1 proteins have variable C-terminal substrate recognition domains that 
recruit and induce the proteasomal degradation of host proteins involved in IFN and ISG 
expression (137, 138). The NSP1 C-terminal domain of most human and porcine 
rotaviruses target β-transducin repeat-containing protein (β-TrCP) for degradation (143), 
a protein critical for activation of the transcription factor, nuclear factor-κB (NF-κB) (Fig. 
3-1A). In contrast, the target of many animal rotaviruses, including simian, bovine, 
equine, and murine strains, are the IRF regulatory factors (e.g., IRF3 and IRF7) (136-
138).  
Human and porcine NSP1 proteins recognize β-TrCP through the presence of a 
DSGXS motif in their C-terminal substrate recognition domain (Fig. 3-1B, C). This motif 
mimics the DSGΦXS degron present in inhibitor of NF-κB (IκB) (138). When bound to 
NF-κB, IκB prevents movement of the NF-κB p65-p50 heterodimer from the cytoplasm 
to the nucleus where the transcription factor stimulates IFN and ISG promoter activity 
(Fig. 3-1A) (179). Induction of upstream innate immune signaling cascades by viruses 
and other pathogens triggers phosphorylation of the IκB degron by the IκB kinase (IKK) 
complex (171). Recognition of IκB’s phosphorylated degron (phosphodegron) by β-
TrCP, a substrate adaptor of an E3 ubiquitin ligase, triggers IκB ubiquitination and 
proteasomal degradation, allowing nuclear translocation of the NF-κB heterodimer (171). 
By recruiting β-TrCP to its C-terminal IκB-like degron (ILD), NSP1 is able to interfere 
with the interaction of β-TrCP with phosphorylated IκB, thus thwarting β-TrCP-mediated 
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degradation of IκB and NF-κB activation. Indeed, mutagenesis and deletion analyses 
have indicated that the NSP1 C-terminal ILD has an essential role in the formation of 
NSP1-β-TrCP complexes and in the degradation of β-TrCP in infected cells (138).  
Recent studies by Lutz et al (145) and Ding et al (144) suggest that NSP1 induces 
β-TrCP degradation by functioning as a substrate adaptor subunit of hijacked E3 cullin-
RING ligases (CRLs). CRLs are large multicomponent assemblages that coordinate the 
activities of many cellular processes, including innate immune responses to viral 
infection (157), by facilitating directed degradation of substrates. Central to CRL 
function, a cullin scaffold protein bridges ubiquitin-charged E2 conjugating enzymes to 
substrates anchored to substrate adaptor proteins. Modification of the cullin component 
by neddylation activates the CRL, resulting in the transfer of ubiquitin from the E2 onto 
the substrate (157, 163).  NSP1 is believed to be a component of a cullin-3 CRL (Cul3 
CRL) with specificity for β-TrCP. In contrast, the E3 ligase responsible for targeting IκB 
for proteasomal degradation is assembled on a cullin-1 (Cul1) scaffold that anchors a 
substrate recognition complex consisting of Skp1 and the F-box adaptor protein β-TrCP; 
this E3 is termed the Skp1-Cul1-F-box (SCFβ-TrCP) CRL (165, 179).  
Because of its critical role in innate immune responses, the function of the SCFβ-
TrCP CRL and its components are primary targets of viral proteins made by viruses in 
addition to rotavirus (220). For example, through its interaction with β-TrCP, HIV Vpu 
redirects the activity of the SCFβ-TrCP CRL, causing the ubiquitination and degradation of 
CD4 (150, 185). Similarly, by sequestering β-TrCP, the vaccinia virus A49 protein 





Figure 3-1. Targeting of the interferon activation pathway by rotavirus NSP1. (A) 
Recognition of viral dsRNA causes host RNA sensors RIG-I, MDA5 and/or TLR3 to 
interact with MAVS and TRAF adaptor proteins, activating the kinases IKK and TBK1. 
IKK  directs the phosphorylation of serine residues in the DSGϕXS motif of inhibitor of 
NF-κB (IκB), generating a phosphodegron that is recognized by β-TrCP, a substrate 
adaptor of an E3 cullin-RING ligase. β-TrCP mediates the ubiquitination and degradation 
of IκB, freeing the NF-κB subunits to translocate to the nucleus and promote IFN 
expression. TBK1 directs phosphorylation of the interferon-regulatory factors IRF3/7, 
inducing their dimerization and nuclear translocation and further stimulating IFN 
expression. (B) Key features of NSP1 proteins include a conserved N-terminal RING-like 
domain and a variable C-terminal substrate targeting domain. The C-terminal targeting 
domain of OSU NSP1 includes an ILD motif (underlined). (C) Above line: Alignment 
revealing the presence of ILDs in the NSP1 proteins of common porcine (OSU) and 
human (Wa and DS1) virus strains, but absence in the NSP1 proteins of bovine (UK), 
simian (SA11-4F, RRV), and murine (EW) virus strains. Below line: IκB-like degron 
sequences within other known binding partners of β-TrCP, including the HIV Vpu and 




A49 protein does not function as part of an E3 ligase and is not associated with β-TrCP 
degradation. 
Phosphorylation of the IκB degron by the IKK kinase complex triggers a 
sequence of events leading to the assembly of the SCFβ-TrCP CRL that induces IκB 
degradation and promotes NF-κB activation (181). Whether rotavirus NSP1 relies on a 
similar pathway to assemble Cul3 CRLs targeting β-TrCP for degradation is unknown. In 
this study, we determined that the NSP1 ILD is phosphorylated and that the kinase 
responsible for this modification is the constitutively active casein kinase II (CKII), 
rather than the kinase (IKK) that phosphorylates the IκB degron. Moreover, we have 
found that phosphorylation of the NSP1 ILD not only enables formation of a stable 
NSP1-β-TrCP complex, but also triggers changes involving the NSP1 N-terminal RING 
domain that result in Cul3 interaction. Thus, CKII phosphorylation is a critical initiating 
event not only in the ability of NSP1 to recruit β-TrCP, but also in its ability to 
incorporate itself into a CRL that induces the ubiquitination and degradation of β-TrCP. 
 
Materials & Methods 
Cells and viruses. Human embryonic kidney HEK293T cells were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) (Gibco), 2 
mM glutamine, and 1,000 units per ml each penicillin and streptomycin. Human 
colorectal HT29 cells were grown in McCoy’s 5A (modified) medium containing 10% 
FBS and penicillin-streptomycin. African green monkey fetal kidney (MA104) cells were 
grown in Medium M199 containing 10% FBS and penicillin-streptomycin. Porcine PK15 
cells were grown in EMEM containing 10% FBS and penicillin-streptomycin. 
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Rotaviruses were propagated and titered by plaque assay on MA104 cells as described by 
Arnold et al (221). Prior to infection, rotaviruses were activated by treatment with 5 µg 
per ml of porcine pancreas trypsin (type IX-S; Sigma-Aldrich) for 1 h at 37°C. The 
monoreassortant rotavirus strains SOF, SKF, SDF, and SRF were a kind gift of 
Nobumichi Kobayashi (222). 
  
Antibodies. Rabbit polyclonal antibodies to simian SA11-5S and porcine OSU NSP1 
proteins (137) and PCNA (Santa Cruz Biotech [SCB], sc-7907), rabbit monoclonal 
antibody to β-TrCP (Cell Signaling Technology [CST], #11984S), and mouse 
monoclonal antibodies to IκB (CST, #4814), p-IκB (CST, #9246), and CKIIa (SCB, sc-
373894) were used at 1:5,000 dilution. Mouse monoclonal antibody to Halo tag 
(Promega, #G928A) and rabbit polyclonal antibodies to Cul1 (Bethyl Lab [BL], #A303-
373A), cyclophilin B (CST, #D1V5J), and Cul3 (BL, #A301-109A) were used at 1:1000 
dilution. Rabbit polyclonal anti-enterokinase cleavage (DDDDK) antibody (BL, #A190-
102A) was used at 1:10,000 dilution to detect FLAG tags. HRP-conjugated goat anti-
rabbit IgG antibody (CST, #7074) and horse anti-mouse IgG antibody (CST, #7076) were 
used at 1:10,000 dilution. 
  
Inhibitors. The protein kinase CKII inhibitor, 4,5,6,7-tetrabromobenzotriazole (TBB) 
(Tocris Bioscience) and the small molecule inhibitor of Nedd8-activating enzyme, 
MLN4924 (Cayman Chemical), were prepared as 1 mM stocks in dimethyl sulfoxide 
(DMSO), which were stored at -20°C. TBB and MLN4924 were diluted in cell culture 
medium to final concentrations of 80 and 1 µM, respectively, immediately prior to use. 
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TNF-α (Sigma) was dissolved in water at a concentration of 25 mg/ml and diluted in 
media to a final concentration of 25 ng/ml. MG132 (Sigma) was dissolved in DMSO and 
diluted in media to a final concentration of 15 mM. 
  
Plasmids. The construction of CMV-expression vectors, pLIC6 and pLIC6F, used for 
transient expression of wild type and mutant forms of NSP1 or FLAG-tagged β-TrCP, 
were described previously (138). pcDNA3-DN-hCUL3-FLAG was a gift from Wade 
Harper (Addgene plasmid # 15820). pHTN-NSP1(OSU) was kindly provided by 
Michelle Arnold (145). Plasmids were grown in TOP10 E. coli (ThermoFisher), purified 
using NucleoBond Xtra endotoxin-free plasmid purification kits (Clontech), and verified 
by sequencing. 
 
Transfections. For transient protein expression, transfection mixtures containing 94 µl 
Opti-MEM [Gibco], 1 mg vector DNA, and 2 µl Lipofectamine 2000 [Invitrogen]) were 
placed in wells of a 12-well cell-culture plate. Afterwards, 0.9 ml HEK293T cell 
suspension (1.3 × 106 cells per ml) in DMEM containing FBS was added to each well. At 
24 h p.t., cell monolayers were rinsed with phosphate-buffered saline (PBS, pH 7.4) and 
lysed in a 200-µl solution of 1× radioimmunoprecipitation assay (RIPA) buffer (150 mM 
NaCl, 50 mM Tris-HCl, pH 8.0, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate) containing 1× phosphatase inhibitor cocktail (1 mM each sodium 
fluoride, sodium orthovanadate, β-glycerophosphate, and sodium pyrophosphate), and 1× 
Complete EDTA-free protease inhibitor cocktail (Roche). Lysates were incubated on ice 
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for 30 min with vortexing every 10 min, and clarified by centrifugation for 10 min at 
15,000 x g at 4°C. 
For RNAi experiments, CKII-directed siRNA (Dharmacon SMARTpool ON- 
TARGETplus CSNK2A1 siRNA, #L-003475-00) or scrambled control siRNA (ON-
TARGETplus non-targeting pool, #D-001810-10) was added to siLentFect (BioRad, 
#1703360) immunoblot assay. 
 
Viral infection. Nearly confluent monolayers of HT29 cells in 10 cm2 tissue-culture 
dishes were infected at an MOI of 5 with trypsin-activated rotavirus. After a one-hour 
adsorption period, virus inoculum was removed and cell monolayers rinsed with PBS. 
Cell monolayers were then maintained in serum-free McCoy’s 5A (modified) medium 
until time of harvest. Cell lysates were prepared by washing monolayers with cold PBS 
and scraping cells into 0.5 ml RIPA lysis buffer. Lysates were incubated on ice for 10 
min, gently mixed, and clarified by centrifugation for 10 min at 15,000 x g at 4°C. 
 
Immunoblot assay. Protein samples were mixed with NuPAGE LDS sample buffer 
(Invitrogen) containing 50 mM dithiothreitol (DTT), denatured by heating to 70°C for 10 
min, and resolved by electrophoresis on pre-cast 10% Tris-glycine polyacrylamide gels 
(Novex). Molecular weight markers (SeeBlue Plus2, Invitrogen; EZ-Run, Fisher 
Scientific) were resolved in parallel to determine protein sizes. Proteins were transferred 
from gels onto nitrocellulose membranes using an iBlot dry transfer apparatus 
(ThermoFisher). Membranes were blocked by incubation in 5% Carnation dry milk 
dissolved in PBS-0.2% Tween-20 (PBST) prior to incubation with primary antibody 
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diluted in milk-PBST solution. Membranes were washed with PBST before incubating 
with HRP-conjugated secondary antibody diluted in milk-PBST solution. Membranes 
were washed with PBST and developed using Super Signal West Pico chemiluminescent 
substrate (Pierce). Signal was detected by exposing membranes to BioExcell X-ray film 
or using the Azure Series c500 Infrared Imaging System. Bands of interest were 
normalized to the loading control PCNA. 
 
In-blot phosphatase treatment. Protein samples were resolved by electrophoresis on 
10% polyacrylamide gels and transferred onto nitrocellulose membranes, as described 
above. Membranes were blocked by incubation at room temperature in 5% BSA 
dissolved in PBST. Afterwards, membranes were incubated overnight at room 
temperature in a solution containing 100 units per ml of calf alkaline intestinal 
phosphatase (CIP, NEB M0290S), 100 mM NaCl, 50 mM Tris-HCl (pH 7.9), 10 mM 
MgCl2, and 1 mM DTT. Following an additional 30-min incubation at 37°C, membranes 
were rinsed with PBST and probed by immunoblot assay. 
 
Immunoprecipitation. Nearly confluent monolayers of HEK293T cells in 10-cm2 dishes 
containing 10 ml of media were transfected by adding plasmid DNA mixtures prepared 
from 1.4 ml Opti-MEM, 7.5 µg each pLIC6-NSP1 and pLIC6F-β-TrCP or pcDNA3-DN-
hCUL3-FLAG, and 29 µl Lipofectamine 2000. Transfected cells were incubated for 24 h 
at 37° C, harvested by resuspending into media, and recovered by low speed 
centrifugation (5 min at 500 x g). Cell pellets were rinsed twice with cold PBS and 
disrupted by resuspension in IP lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 
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1% Triton X-100, with 1× Complete EDTA-free protease inhibitor cocktail). After 
incubation on ice for 1 h, cellular debris were removed by centrifugation at 14,000 x g for 
10 min. Fifty µl of a slurry of anti-FLAG M2 magnetic beads (Sigma, #M8823), pre-
rinsed 3-times with IP wash buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4), was added 
to clarified cell lysates. After overnight incubation at 4°C with nutation, M2 beads were 
recovered using a BioRad Surebeads magnetic stand and rinsed 3 times with IP wash 
buffer. Protein was released from M2 beads by nutation in IP elution buffer (0.1 M 
glycine, pH 3.0) for 5 min at 4°C. Eluted proteins were examined by gel electrophoresis 
and immunoblot analysis. 
 
Results 
The NSP1 ILD is phosphorylated. The interaction of β-TrCP with IκB requires 
phosphorylation of the two serine residues in the IκB degron, DSGΦXS(8). By 
extrapolation, interaction of β-TrCP with NSP1 may similarly require phosphorylation of 
the two serine residues in the NSP1 C-terminal ILD, DSGXS. To determine whether 
NSP1 was phosphorylated, we transiently expressed various untagged forms of NSP1 in 
HEK293T cells including wild type OSU NSP1 (WT) and a C-truncated form of OSU 
NSP1 lacking the ILD (DC13) (Fig. 3-2A, B). Also expressed were two chimeras 
produced by combining portions of the OSU and SA11-4F NSP1 proteins. The OSU-4F 
chimera is identical in sequence to OSU NSP1 except that its last 8 residues have been 
replaced with the corresponding region of SA11-4F NSP1. Thus, the OSU-4F NSP1 
chimera lacks an ILD. In contrast, the 4F-OSU chimera is identical in sequence to SA11-
4F NSP1 except that its last 12 residues have been replaced with the corresponding 
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region of OSU NSP1. Thus, the 4F-OSU NSP1 chimera contains an ILD. The 
phosphorylation status of transiently expressed WT and DC13 NSP1 and OSU-4F and 
4F-OSU chimeras was examined by immunoblot assay using a monoclonal antibody (p-
IκB) that specifically recognizes the fully phosphorylated form of the IκB degron 
(DpSGΦXpS). The assay showed that only those NSP1 proteins containing an ILD (WT, 
4F-OSU) were recognized by p-IκB antibody (Fig. 3-2B). These results suggest that OSU 
NSP1 is a phosphoprotein and that its ILD undergoes phosphorylation. 
To further evaluate the possibility that the ILD of OSU NSP1 was 
phosphorylated, blots of transiently expressed WT and DC13 NSP1 and OSU-4F and 4F-
OSU chimeras were incubated with calf intestinal alkaline phosphatase (CIP) prior to 
probing with p-IκB antibody. The analysis demonstrated that CIP pre-treatment reduced 
recognition of WT and 4F-OSU NSP1 by p-IκB antibody (Fig. 3-2B). Similar results 
were obtained utilizing HALO-tagged OSU NSP1 (H-NSP1) in place of untagged NSP1 
(Fig. 3-2C). CIP pre-treatment reduced recognition of H-NSP1 by p-IκB antibody, even 
though the protein remained present as determined using anti-HALO antibody. Likewise, 
in control experiments, CIP treatment reduced recognition of p-IκB formed in cells 
treated with tumor necrosis factor alpha (TNF-α), a cytokine that upregulates IKK and 
activates NF-κB (Fig. 3-2B). The importance of the ILD in recognition of NSP1 by p-IκB 
antibody was also investigated by mutagenesis. This analysis showed that alanine 
replacement of serine residues in the IκB-like DSGXS motif, either individually or in 




Figure 3-2. Phosphorylation of transiently expressed OSU NSP1. (A) Alignment of C-
terminal NSP1 sequences and a portion of IkB containing the DSGΦXS phosphodegron. 
Red lettering indicates OSU-specific residues. The phosphodegron region is boxed. (B) 
HEK293T cells were transfected with NSP1 expression vectors or maintained in the 
presence of MG132 with or without TNF-a beginning at 20 h p.t. Lysates prepared from 
cells at 24 h p.t. were resolved by gel electrophoresis, in duplicate, and blotted onto 
nitrocellulose membranes. Membranes were mock treated (-CIP) or treated with calf 
alkaline intestinal phosphatase (+CIP) in parallel. Mock-and CIP-treated membranes 
were probed with PCNA antibody, p-Ik B antibody to detect phosphorylated NSP1 (p-
NSP1) and Ik B (p-Ik B), OSU NSP1 antibody to detect OSU and 4F-OSU NSP1, and 
SA11-5S antibody to detect SA11-4F and 4F-OSU NSP1. (C) Lysates prepared from 
HEK293T cells transfected with expression vectors for OSU NSP1 (OSU) or HALO-
tagged OSU NSP1 (H-OSU) were resolved by gel electrophoresis and blotted onto 
nitrocellulose membranes, in duplicate. Mock- and CIP-treated membranes were probed 
with p-IκB antibody to detect p-NSP1 and with antibodies to the HALO tag and PCNA. 
Levels of phosphorylated H-OSU were calculated relative to PCNA levels and 
normalized to 100% for the untreated sample. Data are from two independent 




Together, these findings indicate that the ILD of OSU NSP1 is phosphorylated in a 
manner mimicking the IκB degron, with both serine resides of the DSGXS motif 
phosphorylated. 
 
NSP1 encoded by various rotavirus strains is phosphorylated. To assess whether 
NSP1 proteins expressed during infection were phosphorylated, human HT29 cells were 
infected with rotavirus strains OSU, SA11-4F, and SA11-5S, and with a panel of mono-
reassortant rotaviruses containing various segment 5 RNAs in an SA11-L2 background. 
The reassortant viruses included SOF, SKF, SDF, and SRF, which express the NSP1  
proteins of porcine OSU, human KU, human DS-1, and simian RRV strains, respectively. 
Of these NSP1 proteins, only those encoded by OSU, KU, and DS1 viruses contain an 
ILD (Fig. 3-4A). Rotavirus-infected HT29 cells were harvested at 10 h p.i., and proteins 
in HT29 lysates were analyzed by immunoblot assay using p-IκB antibody. The results 
showed that those NSP1 proteins containing an ILD were recognized by p-IκB antibody 
(Fig. 3-4B). Thus, NSP1 proteins with ILDs undergo phosphorylation in rotavirus- 
infected cells and this protein modification occurs for rotavirus strains isolated from a 
variety of animal species (e.g., human, simian, porcine). OSU, KU, and DS1 NSP1 
proteins produced in rotavirus-infected simian MA104 and porcine PK15 cells were 
similarly recognized by p-IκB antibody suggesting that phosphorylation of the ILD takes 
place regardless of the species origin of the host cell line (data not shown). While our 
results showed that SA11-4F and RRV NSP1 proteins were not recognized by the p-IκB 
antibody, these data do not exclude the possibility that these proteins are phosphorylated 




Figure 3-3. Effect of priming loop mutations on NSP1 phosphorylation. (A) Lysates 
prepared from HEK293T cells expressing wild type (WT) OSU NSP1 and forms of the 
protein with the indicated mutations were analyzed by immunoblot assay using p-Ik B 
antibody to recognize p-NSP1, OSU NSP1 antibody, and PCNA antibody. (B) Predicted 
phosphorylation patterns of the OSU NSP1 ILD by CKI and CKII using D477 and E486 
















NSP1 is phosphorylated by CKII. Interaction of β-TrCP with IκB is dependent on 
phosphorylation of the IκB degron by the IKKβ subunit (223). To determine whether the 
NSP1 ILD motif was phosphorylated by the same kinase, or a different one, the 
Eukaryotic Linear Motif resource (elm.eu.org) (224) was used to identify potential kinase 
recognition motifs in NSP1 protein. The analysis indicated that NSP1 proteins with an 
ILD lack a recognition site for IKKβ kinase. Instead, the NSP1 ILD was found to be 
situated within recognition motifs for casein kinase I (CKI) and II (CKII) (Fig. 3-3B) 
(138). CKI and CKII direct phosphorylation after priming at a negatively charged amino 
acid residue (e.g., aspartic acid, glutamic acid) located three positions upstream or 
downstream of a target serine residue, respectively (225-227). Examination of NSP1 
proteins indicates that such amino acids are present at the putative priming positions for 
CKI and CKII in the NSP1 ILD motif [(D/E)YDSGISDVE] (priming positions are 
underlined, phosphoserines are in bold). Whether CKI or CKII was involved in NSP1 
phosphorylation was examined by transient expression of OSU NSP1 proteins in which 
the putative priming residues had been mutated. The results showed Glu>Gln mutation of 
the putative CKII priming residue prevented recognition of OSU NSP1 by p-IκB 
antibody, whereas Asp>Asn mutation of the putative CKI priming residue did not (Fig. 3-
3A). These mutagenesis data indicate that CKII is responsible for phosphorylation of the 
NSP1 ILD. 
To further evaluate the importance of CKII activity on NSP1 phosphorylation, 
HEK293T cells were transfected with a vector expressing HALO-tagged OSU NSP1 and 
either siRNA specific for CKII RNA or a scrambled control siRNA pool (Fig. 3-5A-C). 




Figure 3-4. Phosphorylation of NSP1 in rotavirus-infected cells. (A) Alignment of C-
terminal sequences of NSP1 proteins with the ILD boxed.  (B) HT29 cells were infected 
with SA11-4F, SA11-5S, or OSU virus strains or mono-reassortant SA11-L2 virus strains 
expressing OSU (SOF), KU (SKF), DS-1 (SDF), or RRV (SRF) NSP1. SA11-5S 
expresses a mutant form of NSP1 that lacks the 13-terminal residues of wild type SA11-
4F NSP1. Lysates prepared from the infected cells at 15 h p.i. were analyzed by 
immunoblot assay using p-Ik B antibody to detect p-NSP1 and PCNA antibody. To detect 
total NSP1, lysates from mock-, SA11-4F-, and SA11-5S-infected cells were probed with 
antibody made against SA11-5S NSP1, lysates from OSU-, SOF-, SKF-, and SDF-
infected cells were probed with antibody made against OSU NSP1, and the lysate from 










levels of CKII expression and phosphorylated NSP1 (Fig. 3-5B, C), relative to treatment 
with scrambled siRNAs, supporting the hypothesis that CKII mediates phosphorylation 
of the NSP1 ILD. The contribution of CKII to NSP1 phosphorylation was also examined 
by treating OSU-infected human HT29 and porcine PK15 cells with 4,5,6,7-
tetrabromobenzotriazole (TBB), a highly-specific cell-permeable nucleoside inhibitor of 
CKII (228). Whole-cell lysates prepared from the infected cells at 4 and/or 9 h p.i. were 
analyzed by immunoblot analysis using an antibody specific for the OSU NSP1 RING 
domain (anti-RING antibody) to detect total NSP1 and the p-IκB antibody to detect 
nucleoside inhibitor of CKII (228). Whole-cell lysates prepared from the infected cells at 
4 and/or 9 h p.i. were analyzed by immunoblot analysis using an antibody specific for the 
OSU NSP1 RING domain (anti-RING antibody) to detect total NSP1 and the p-IκB 
antibody to detect phosphorylated NSP1 and IκB proteins (Fig. 3-5D, E). The results 
showed that TBB inhibited the accumulation of phosphorylated NSP1 in both HT29 and 
PK15 infected cells.  The detection of NSP1 in TBB-treated cells with the anti-RING 
antibody ruled out the possibility that the inhibitor prevented NSP1 expression. Taken 
together, the results obtained using CKII siRNAs and TBB demonstrate that CKII is 
responsible for phosphorylation of the NSP1 ILD.  
 
NSP1 phosphorylation is required for NSP1-β-TrCP interactions. Because IκB must 
undergo phosphorylation for interaction with β-TrCP (171), we predicted that NSP1 may 





Figure 3-5. Effect of CKII inhibition on NSP1 phosphorylation. (A) HEK293T cells were 
co-transfected with a vector expressing HALO-tagged NSP1 (H-NSP1) and a 10 or 50 
mM siRNA pool targeting the CKII RNA or representing a scrambled siRNA control 
pool. At 48 h p.t., cells were collected and proteins samples analyzed by immunoblot 
assay with antibodies specific for HALO tag, p-NSP1, CKIIα, and PCNA. Band 
intensities from two independent experiments using 50 mM concentration of siRNA pools 
were determined with an Azure digital imager. (B) Levels of OSU NSP1 phosphorylation 
were calculated by dividing p-NSP1 intensity values by those for H-NSP1 and 
normalizing the results to 100% for the control siRNA sample. (C) CKII levels were 
calculated by dividing CKII intensity values by those for PCNA and normalizing the 
results to 100% for the control siRNA sample. (D) HT29 cells were infected with OSU at 
an MOI of 5, and treated with TBB or DMSO at 2 h p.i. At 4 and 9 h p.i., cells were 
collected and lysed, and proteins in the samples were resolved by electrophoresis and 
examined by immunoblot assay using antibodies recognizing OSU NSP1, p-NSP1, p-IκB, 
β-TrCP, and PCNA. (E) PK15 cells were infected with OSU at an MOI of 5, and mock 
treated or treated with TBB. Cells were harvest at 9 h p.i., and proteins in the samples 





possibility, FLAG-tagged β-TrCP was transiently expressed in HEK293T cells with WT 
NSP1 or mutant forms of NSP1 that lacked either an ILD (dC13) or the CKII priming 
residue (E486Q), or that contained a mutation of a conserved cysteine residue in the N-
terminal RING domain (C42A). FLAG-tagged β-TrCP (F-β-TrCP) was recovered from 
lysates prepared from the transfected cells by affinity purification with anti-FLAG resin, 
and proteins co-purifying with β-TrCP were identified by immunoblot assay. The results 
indicated that WT NSP1 and NSP1 with a mutated RING domain (C42A) interacted with  
F-β-TrCP (Fig. 3-6). In contrast, NSP1 that lacked an ILD motif (DC13) or that was 
unable to undergo CKII phosphorylation (E486Q) did not form complexes with F-β-TrCP 
(Fig. 6). These data indicate that NSP1 must contain a phosphorylated ILD for stable 
interaction with β-TrCP. Interestingly, the data also suggest that the NSP1 RING domain 
may not have a role in modulating NSP1-β-TrCP interactions, since the NSP1 RING 
mutant C42A retained binding activity for β-TrCP. 
 
NSP1 phosphorylation is required for incorporation into CRLs. Previous reports 
have indicated that NSP1 functions as a substrate adaptor of Cul3 CRLs (144, 145). To 
address whether incorporation of NSP1 into Cul3 CRLs is influenced by the 
phosphorylation status of the NSP1 ILD, we transiently expressed F-β-TrCP with WT 
NSP1 or mutant NSP1 proteins C42A or E486Q in HEK239T cells. We stabilized CRLs 
that formed in transfected cells by the addition of MLN4924, a NEDD8-activating 
enzyme inhibitor that inhibits cullin neddylation and CRL disassociation (229). 
Immunoprecipitates containing F-β-TrCP were recovered from transfected-cell lysates 




Figure 3-6. Influence of NSP1 phosphorylation on interactions with β-TrCP. HEK293T 
cells were transfected with vectors expressing FLAG-β-TrCP and WT or mutant OSU 
NSP1. Lysates prepared from the cells at 24 h p.t. were incubated with anti-FLAG resin 
to immunoprecipitate (IP) complexes containing FLAG-β-TrCP. Input fractions and 
eluted proteins were analyzed by immunoblot assay with antibodies specific for NSP1, 
FLAG, p-NSP1, p-IκB, and PCNA. The OSU NSP1 antibody was generated using a 
peptide representing the C-terminus of the OSU NSP1 proteins (137). As a result, the 












Characterization of the immunoprecipitates indicated that F-β-TrCP interacted with 
neddylated and non-neddylated forms of Cul1, consistent with previous reports showing 
that β-TrCP is a component of the SCFβ-TrCP E3 ligase (Fig. 3-7A). The analysis also 
indicated that F-β-TrCP interacted with WT and C42A p-NSP1, but not with E486Q 
NSP1 (Fig. 3-7A). This finding argues that the interaction of β-TrCP with NSP1 is 
dependent on phosphorylation of the NSP1 ILD, consistent with data presented in Fig. 3-
6. Surprisingly, analysis of F-β-TrCP immunoprecipitates recovered from cells 
expressing C42A NSP1 indicated that C42A NSP1-β-TrCP complexes were formed that 
contained CKII, the kinase responsible for phosphorylation of the NSP1 ILD (Fig 3-7A). 
In contrast, relatively little CKII was detected in F-β-TrCP immunoprecipates recovered 
from cells in which F-β-TrCP was co-expressed with WT NSP1 or a mutant form of 
NSP1 that cannot undergo phosphorylation (E486Q). These data suggest that CKII has 
affinity for NSP1 and that the interaction between the two proteins requires the CKII 
E486 priming residue and/or phosphorylation of the NSP1 ILD. Moreover, these data 
suggest that CKII interaction with the NSP1-β-TrCP complex does not require a WT 
RING domain in the NSP1 protein. 
More Cul3 appeared to be present in F-β-TrCP immunoprecipitates recovered 
from transfected cells in which F-β-TrCP was co-expressed with WT NSP1 than with 
C42A or E486Q NSP1 (Fig. 3-7A). To further evaluate this possibility, we transiently 
expressed FLAG-tagged dominant negative Cul3 [F-(DN)Cul3] with WT, C42A, or 
E486Q NSP1 in HEK293T cells (Fig. 3-7B). (DN)Cul3 is a carboxyl truncated form of 
Cul3 that forms stable complexes with F-box adaptor proteins and substrates but is 
unable to interact with Rbx1 and the E2 ubiquitin-conjugating enzyme (166). 
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Immunoblot analysis of F-(DN)Cul3 immunoprecipitates indicated that WT NSP1, but 
neither NSP1 with a mutated RING motif (C42A) nor a phosphorylation-defective ILD 
motif (E486Q), interacted with Cul3 (Fig. 3-7B). These results suggest that the NSP1 
RING domain plays an important role in NSP1-Cul3 interactions, and consequentially, 
the incorporation of NSP1 into Cul3 CRLs. However, the fact that E486Q NSP1 did not 
bind Cul3, despite the presence of a WT RING domain, argues that the CKII E486 
priming residue and/or phosphorylation of the NSP1 ILD motif precedes the activity of 
the RING domain in promoting NSP1-Cul3 interactions. Taken together, this data 
suggests an ordered association of NSP1 with CRLs and its protein target; NSP1 
interactions with CKII lead to phosphorylation of its C-terminal ILD and binding to β-
TrCP targets, followed by CKII release and Cul3 binding. 
 
Relationship between NSP1 phosphorylation and β-TrCP degradation. The results 
presented above indicate that the interaction of phosphorylated NSP1 with β-TrCP is not 
dependent on the incorporation of NSP1 into a CRL, raising the question of whether 
NSP1 could inhibit NF-kB-activation simply sequestering by β-TrCP away from its IκB 
target. To examine this possibility, HT29 cells were mock infected or infected with OSU 
rotavirus. Lysates prepared from the cells at 2, 4, 6, 8, and 10 h p.i. were analyzed by 
immunoblot assay using antibodies recognizing phosphorylated NSP1 and IκB, and β-
TrCP (Fig. 3-8). The analysis showed that NSP1 was initially detected by 4 h p.i., with 
levels sharply increasing by 6 h p.i. Phosphorylated NSP1 was first observed by 6 h p.i., 
with levels further increasing until 8 h p.i. Phosphorylated IκB was initially detected by 4 





Figure 3-7. Effect of NSP1 phosphorylation on interactions with Cul3. HEK293T cells 
were transfected with vectors expressing WT or mutant C42A or E486Q OSU NSP1 and 
(A) FLAG-β-TrCP or (B) FLAG (F)-DN-Cul3. Transfected cells were mock treated or 
treated with the neddylation inhibitor MLN4964 (MLN). Lysates prepared from the cells 
at 24 h p.t. were incubated with anti-FLAG resin to immunoprecipitate (IP) complexes 
containing FLAG-tagged proteins. Input fractions and eluted proteins were analyzed by 
immunoblot assay with antibodies specific for Cul1, Cul3, NSP1, p-NSP1, FLAG, CKIIα 
and cyclophilin B. 
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markedly increased by 6 h p.i. and remained high through at least 10 h p.i., suggesting a 
failure of β-TrCP to efficiently recruit and induce the degradation of IκB in the infected 
cell. Notably, degradation of β-TrCP was not apparent until after 6 to 8 h p.i., well after 
significant accumulation of phosphorylated IκB was observed. Thus, even though β-TrCP 
was present in infected cells at 6 to 8 h p.i., its presence was not correlated with the 
degradation of phosphorylated IκB. These results raise the likelihood that β-TrCP 
degradation may not be the only mechanism used by NSP1 to inhibit IκB degradation and 
NF-κB activation. Instead, it is possible that NSP1 can accomplish these tasks simply by 




In this study, we have determined that rotavirus NSP1 is phosphorylated and that 
this modification represents a critical initiating event in the interaction of NSP1 with β-
TrCP and in the incorporation of NSP1 into Cul3-CRLs. (Fig. 3-9). Our analysis indicates 
that both serine residues in the OSU NSP1 ILD (DSGXS) undergo phosphorylation, 
mimicking phosphorylation of the two conserved serine residues of the IκB degron. The 
NSP1 proteins of all tested rotaviruses containing an ILD were phosphorylated, 
regardless of the species origin of the virus or the species origin of the cell line used to 
grow the virus. The phosphorylated NSP1 proteins included those belonging to genotypes 
A1 and A2, representing the types of NSP1 genes found in nearly all rotaviruses causing 





Figure 3-8. Accumulation of p-NSP1, β-TrCP, and p-IκB during viral infection. HT29 
cells were mock infected or infected with OSU rotavirus (MOI of 5) and harvested from 
2 to 10 h p.i. Cellular lysates were resolved by gel electrophoresis and transferred onto 
nitrocellulose membranes. Blots were probed with antibodies specific for NSP1, p-NSP1, 















cells transfected with CMV transcription vectors or expressed in rotavirus-infected cells, 
were phosphorylated. There was no evidence suggesting that other rotavirus gene 
products were necessary or affected NSP1 phosphorylation. Experiments performed with 
the NSP1 C42A mutant indicated that the protein’s N-terminal RING region does not 
have a role in regulating ILD phosphorylation.  
Phosphorylation assays carried out with small molecule inhibitors, siRNAs and 
mutagenized expression vectors all indicated that CKII, a ubiquitous constitutively-active 
serine-threonine kinase (230), was responsible for phosphorylation of the NSP1 ILD. 
Based on the time course experiment presented in Fig. 3-8, phosphorylated NSP1 is 
detected in OSU-infected cells at approximately the same time  (6 h p.i.) that NSP1 
begins to accumulate (Fig. 3-8). Thus, NSP1 is likely primed for interaction with β-TrCP 
soon after synthesis, in contrast to IκB, which is dependent on activation of the upstream 
IKK signaling cascade to undergo phosphorylation (179). Indeed, by utilizing CKII, 
NSP1 can potentially undergo phosphorylation and target β-TrCP for degradation before 
pathogen recognition receptors of infected cells have triggered innate immune signaling 
pathways and IκB phosphorylation. Our co-immunoprecipitation studies suggest that 
CKII not only phosphorylates the NSP1 ILD, but transiently binds to NSP1 at a step 
antibody, is not known. The source of the CKII kinase activity may be the COP9 
signalsome (231), a multi-subunit protein complex responsible for deneddylating cullins 
and regulating CRL activity (232). Notably, NSP1 is not the only rotavirus protein known 
to be phosphorylated by a cellular kinase during virus replication. In particular, one of the 
major building blocks of rotavirus viroplasms (NSP5) undergoes extensive 





Figure 3-9.  Predicted steps in the CKII-dependent incorporation of NSP1 into a Cul3 
CRL. The constitutively-active kinase CKII interacts with NSP1, leading to 
phosphorylation of the NSP1 ILD. The affinity of β-TrCP for the phosphorylated degron 
results in the formation of an NSP1-β-TrCP-CKII complex. CKII is released as the 
NSP1-β-TrCP complex interacts with the CRL assembly intermediate Cul3 - RBx1. 
Recruitment of a charged E2 conjugating enzyme to Rbx1 results in the formation of a 
















occurring prior to NSP1’s incorporation into CRLs. Whether the entire CKII tetrameric 
complex (233) is bound to NSP1, or just the catalytically subunit recognized by the CKII  
Our co-immunoprecipitation experiments suggest the CKII-NSP1-β-TrCP 
complex is a precursor of the Cul3-NSP1-β-TrCP complex, opening the possibility that 
interaction of Cul3 with NSP1 displaces CKII. Interestingly, the phosphorylation- 
defective NSP1 E486Q mutant does not form a complex with Cul3, supporting a 
hypothesis that phosphorylation of the NSP1 ILD triggers structural changes that must 
occur for the protein to bind Cul3. Whether the putative structural change results from 
just the phosphorylation of the ILD or also requires the binding of β-TrCP remains to be 
addressed. The NSP1 RING mutant C42A failed to form a complex with Cul3 complex, 
pointing to a key role for the RING in the incorporation of NSP1 into a CRL. The RING 
domain, including its C42 residue, is conserved among the NSP1 proteins of group A 
rotaviruses, regardless whether the protein targets β-TrCP or some other protein (e.g., 
IRF3) (234). The same RING domain is present in group C, D, and F rotaviruses (235), 
suggesting that the RING is a highly conserved structural feature necessary for formation 
of an NSP1 Cul3-CRL. Although the conserved RING domain suggests that the group C, 
D, and F rotaviruses incorporate into Cul3-CRLs like the group A rotaviruses, the group 
C, D, and F viruses lack a C-terminal ILD and thus are likely to target host proteins other 
than β-TrCP. The rotavirus RING domain is known to coordinate zinc binding (236); it 
may be the loss of this function and the subsequent failure to form zinc-stabilized fingers 
that prevents the NSP1 C42A mutant from binding to Cul3. There are multiple reports 
indicating that NSP1 is a single-stranded RNA-binding protein, with this activity 
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mapping to the RING domain (146, 236). Thus, NSP1 is likely a multifunctional protein 
with its RING residues contributing to more than one process. 
Many animal group A rotaviruses (e.g., SA11-4F, RRV, EW, K9) encode NSP1 
proteins that target IRF3 and other IRF proteins for degradation, instead of β-TrCP (137). 
The NSP1 of these viruses have a conserved C-terminal LL(I/L)S motif that mediates 
recognition of IRF3. The NSP1 LL(I/L)S motif is a mimic of the recognition motif pLxIS 
(p is hydrophobic) used by adaptor proteins of the IFN signaling pathway (STING, 
MAVS, and TRIF) to recognize IRF3 (237).  Interestingly, the interaction of the adaptor 
protein with IRF3 requires phosphorylation of the serine residue in the pLxIS recognition 
motif by IKK kinase. In contrast, phosphorylation of the its LL(I/L)S is not required for 
interaction of animal NSP1 proteins with IRF3, due to alternative contacts made between 
NSP1-IRF3 that do not involve the serine residue (212).  As a result, NSP1 proteins 
targeting IRF3 need not undergo the same phosphorylation-dependent activation required 
by NSP1 proteins targeting β-TrCP. To avoid the assembly of functionless NSP1-CRLs, 
it seems likely that interactions of IRF3 with the C-terminal end of NSP1 would likely be 
necessary to induce structural changes enabling NSP1 to bind Cul3. 
An important observation made in our experiments was that at relatively early 
times of infection with OSU rotavirus (6 to 8 h p.i.), phosphorylated IkB accumulated 
despite approximately wild type levels of β-TrCP. Because β-TrCP is responsible for the 
degradation of IκB, these results suggested that β-TrCP in the infected cell was being 
rendered inactive without undergoing degradation. This phenomenon could be explained 
by presuming that NSP1 can interfere with IκB degradation simply by binding, and 
sequestering, β-TrCP. Alternatively, it could be that NSP1-mediated ubiquitination of β-
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TrCP is the critical element that prevents β-TrCP and the SCFβ-TrCP from targeting IκB for 
ubiquitination and degradation. In this case, NSP1 could render β-TrCP inactive without 
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Viruses manipulate cellular processes to create an environment favorable to 
replication. For most viruses, this includes subverting the expression of interferon (IFN), 
a signaling molecule that can stimulate production of a vast array of antiviral gene 
products. Rotavirus, a segmented double-stranded RNA virus that causes acute 
gastroenteritis in infants and young children, inhibits IFN expression through its 
nonstructural protein NSP1. This viral protein stifles IFN expression by inducing the 
degradation of host factors that are necessary for upregulating the activity of IFN genes. 
In the case of nearly all human and porcine rotavirus strains, NSP1 induces the 
ubiquitination-dependent proteasomal degradation of β-transducin repeat containing 
protein (β-TrCP), a host factor that plays an essential role in activating the IFN-
transcription factor, NF-κB. Key to the process is the presence of a decoy sequence 
(degron) at the C-terminus of NSP1 that causes β-TrCP to mistakenly bind NSP1 instead 
of its natural target, inhibitor-of-NF-κB (IκB). In a recent report published by Davis et al 
[2017; mBio 8(4) e01213-17], we describe molecular requirements that govern NSP1 
recognition of β-TrCP, including an essential degron phosphorylation event, and the step-
wise incorporation of NSP1 into hijacked cullin-RING E3 ligases (CRLs) that 
ubiquitinate and tag β-TrCP for degradation.  Notably, although β-TrCP is chiefly 
recognized for its role as a master regulator of NF-κB signaling and IFN expression, β-
TrCP also controls the stability of checkpoint proteins implicated in numerous other 
cellular pathways with antiviral activities, including autophagy and apoptosis. Thus, the 
impact of NSP1 on creating an intracellular environment favorable to virus replication 
may extend well beyond the IFN signaling pathway.  
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Viruses have evolved a number of mechanisms to combat host antiviral responses 
in order to establish a pro-viral cellular environment. Many host antiviral responses rely 
on signaling cascades initiated by the production of IFN. To this end, rotavirus, a 
pathogen known to infect nearly all known mammalian and avian animal species, 
employs NSP1 as an IFN antagonist.  NSP1 proteins encoded by various rotavirus strains 
share little sequence conservation except for the presence of a putative N-terminal RING 
domain and a C-terminal substrate-targeting domain. While the targeting domain of most 
human and porcine rotaviruses mediates the recruitment of β-TrCP by NSP1, the 
targeting domain of many animal strains (simian, murine, equine, etc.) mediates the 
recruitment of interferon-regulatory factors (e.g., IRF-3/-7). NSP1 binding to β-TrCP or 
IRF proteins is correlated with proteasomal degradation of these targets in the infected 
cell.  
There is a growing body of data to suggest that NSP1 triggers the degradation of 
targets by hijacking a subset of E3 ubiquitin ligases, cullin-RING ligases (CRLs). 
Hijacked CRLs are presumed to direct the ubiquitination and proteasomal degradation of 
NSP1-bound targets. CRLs are large modular complexes that are minimally comprised of 
several key components: a cullin scaffold protein (Cul1, 2, 3, 4a, 4b, 5, 7), a RING-
domain containing protein (Rbx1, 2), and a substrate adaptor that directs the CRL to the 
target protein. Through multiple experimental approaches, results have been obtained 
indicating that NSP1 associates with components of CRLs, including Cul3, which has led 
to the hypothesis that NSP1 functions a substrate adaptor protein of a Cul3-CRL. A 
recent publication by Davis et al (2017) reveals the highly coordinated sequence of 
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events necessary for NSP1 recruitment of β-TrCP and the integration of the NSP1-β-
TrCP complex into hijacked CRL complexes. 
 NSP1 proteins that target β-TrCP have within their C-termini the sequence 
DSGXS. This sequence is a molecular decoy of the degron sequence, DSGφXS, 
contained in IκB. During activation of IFN signaling pathways, the IκB degron 
undergoes phosphorylation by the serine-threonine kinase activity of IκB kinase (IKK), 
creating a phosphodegron that is recognized by β-TrCP (Fig. 1). Interaction of β-TrCP 
with the IκB phosphodegron leads to IκB degradation, which in turn frees NF-κB to 
translocate to the nucleus and upregulate IFN promoter activity. In a parallel manner, 
binding of β-TrCP to the C-terminal IκB-like degron of NSP1 is dependent on 
phosphorylation. As shown by Davis et al (2017), this phosphorylation event is not only 
required for binding of β-TrCP to NSP1 but is also essential for the subsequent 
incorporation of the NSP1-β-TrCP complex into a CRL (Fig. 2). Unlike the degron of 
IκB, which is dependent on the inducible IKK for phosphorylation, the degron of NSP1 
co-opts the use of the ubiquitously-active serine-threonine kinase CKII for 
phosphorylation. Use of this kinase potentially offers several benefits to the virus. Most 
notably, the NSP1 degron is activated without the need for a kinase, like IKK, that is 
regulated through an immune signaling pathway. Moreover, CKII is associated with CRL 
accessory components (e.g. the COP9 signalosome), possibly placing NSP1 in the 
constant presence of an activating kinase. Through the use of NSP1 mutants and CRL 
inhibitors, Davis et al (2017) obtained data showing that CKII remains associated with 






Figure 4-1. NF-κB induction of interferon. When a host cell detects the presence of an 
invading pathogen, signaling cascades are induced which ultimately lead to interferon 
expression, triggering an anti-viral state in the affected cell. Upstream pathogen detection 
initiates signaling cascades that hinge on the activity of activatable kinases such as the 
IκB kinase complex (IKK). A pool of inactive NF-κB transcription factors exists in the 
cytoplasm, bound to the inhibitor, IκB. Phosphorylation of IκB by IKK leads to its 
recognition by components of an E3 ubiquitin ligase complex, SCFβ-TrCP, leading to IκB 
ubiquitination and degradation. NF-κB, now free of its inhibitor, translocates to the 









NSP1-CKII-β-TrCP complex. Thus, CKII may have a role in the subsequent assembly of 
NSP1-CRLs that extends beyond NSP1 phosphorylation and activation.  
In our Davis et al (2017) publication, we also present data indicating that the 
NSP1-CKII-β-TrCP complex interacts with Cul3 subunits, forming a Cul3-NSP1-β-TrCP 
complex. CKII was released at this step of the assembly process. The CRL3-NSP1-β-
TrCP complex presumably binds a ubiquitin-charged E2 enzyme and its cullin 
component undergoes neddylation, initiating structural changes that facilitate transfer of 
ubiquitin to β-TrCP. Repeated cycles of binding and release of charged and uncharged 
E2s create a poly-ubiquitin chain on β-TrCP that is recognized by the proteasome. 
Interestingly, we found that mutation of the NSP1 RING domain (C42A) created a form 
of NSP1 that although capable of binding β-TrCP and CKII, could not bind Cul3. This 
finding raises the possibility that phosphorylation of the NSP1 IκB-like degron triggers a 
structural change that allows interaction of the N-terminal RING domain with Cul3. 
Considered together, our analyses indicate that formation of NSP1-CRLs is a highly 
ordered process, initiated by CKII-phosphorylation, followed by binding of β-TrCP, and 
ending with the incorporation of NSP1-β-TrCP complexes into a CRL through an 
interaction requiring participation of the NSP1 RING domain. 
β-TrCP has many cellular targets besides IκB. These targets similarly contain 
phosphodegron motifs, and many serve as checkpoint proteins for cellular pathways that 
mediate antiviral activities beyond IFN induction. As one example, β-TrCP is responsible 
for degrading DEPTOR, the protein that binds to and regulates the activity of mTOR, a 
protein kinase that plays a major role in autophagocytic and apoptotic responses. In 





Figure 4-2. A model of NSP1-CRL assembly. Upon expression, NSP1 binds the 
constitutively active kinase CKII and undergoes phosphorylated of the C-terminal degron 
motif. The affinity of β-TrCP for phosphorylated NSP1 results in formation of an NSP1–
β-TrCP–CKII complex. CKII is released as the NSP1–β-TrCP complex incorporates into 
the CRL assembly intermediate Cul3-Rbx1 and recruits a ubiquitin-charged E2 enzyme. 
Nedd8-activated CRLs facilitate ubiquitination of β-TrCP substrates, and multiple rounds 














































cells, promoting maturation of the p105 precursor protein to the NF-κB p50 subunit, and 
processing of the pro-apoptotic procasepase-3 into caspase 3. The diverse influence of β-
TrCP on cellular pathways and antiviral responses, suggests that viral proteins - like 
NSP1 - that prevent β-TrCP activity affect the entire intracellular milieu and may shift the 
cellular atmosphere at multiple levels in favor of virus replication. Indeed, the positive 
implications of attacking β-TrCP on virus replication may explain why other viruses, 
such as HIV, vaccinia virus, and Epstein Barr virus also target this protein. Continued 
efforts to establish how NSP1 antagonizes β-TrCP activity will not only lead to a better 
understanding of the basis of rotavirus pathogenesis, but also provide insight into the 































Part 1: The pLxIS motif does not require phosphorylation for substrate engagement 
Abstract 
 Rotavirus is a non-enveloped, double-stranded RNA virus responsible for 
significant disease worldwide. To combat host innate immune responses, rotaviruses 
encode non-structural protein 1 (NSP1), the product of genome segment 5, which is 
capable of inhibiting key interferon induction cascades. The NSP1 proteins of rotavirus 
species A cluster by both host and by preferred innate immune target proteins, specified 
within the C-terminus of the protein. Wa and OSU-like NSP1 proteins encode a 
phosphodegron motif (DSGIS) in this region to target cellular proteins in NF-κB 
signaling cascades. SA11-like NSP1 proteins that target IRF3 for degradation instead 
conserve a C-terminal pLxIS motif that strongly resembles motifs utilized by MAVS, 
STING and TRIF proteins to bind IRF3. Because of this similarity, we sought to establish 
the relevance of this domain in NSP1 mediated IRF3 degradation. To understand the 
functional role of this conserved sequence, we examined the capacity of mutagenized 
NSP1s to degrade target IRFs or antagonize signaling, and have demonstrated a lack of 
dependence on any single phosphorylated residue. This is contrary to cellular interactions 
with the IRF3 dimerization domain, which requires phosphorylation. Successful 
interactions between NSP1 and IRF3 likely rely instead on the pLxIS leucine residue 
within the motif, demonstrating unusual folding and target interaction of this domain.  
 
Introduction 
 Similar to what has been observed and reported for OSU-like proteins of human 
and porcine rotavirus strains, the SA11-like animal NSP1 proteins are thought to behave 
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as adaptor proteins of CRLs. Ding, et al. (144) and Lutz, et al (145) included NSP1 
proteins from this group of proteins in their analyses, and data strongly supports that like 
OSU, these NSP1 proteins rely on the same or very similarly comprised cellular 
machinery to exert control over host signaling cascades. Unlike OSU related strains, 
these NSP1 proteins are associated with the degradation of IRF proteins.  
Following detection of viral nucleic acids by cGAS (DNA) or RIG-I-like-
receptors (RNA), signaling through the respective proteins STING and MAVs recruits 
kinases, such as IKK or TBK1, in order to activate NF-κB or IRF3 (Figure 5-1) (106).  
TRIF can be similarly activated through upstream detection of lipopolysaccharide by 
TLR4. Activated RIG-I is known to facilitate oligomerization of MAVS, which results in 
recruitment of TRAF2, TRAF5, and TRAF6, and subsequently, activation of IKK and 
TBK1. This leads to phosphorylation of IRF3, and its subsequent dimerization and 
translocation to nucleus, leading to interferon induction. Activated TLR3 and TLR4 
similarly signal through recruitment of TRIF to activate IKK and TBK1. While other 
innate immune sensing pathways result in activation of TBK1, IRF3 activation is only 
induced by pathways that signal through MAVS, STING, or TRIF. Recent data by Liu, et 
al. (237) demonstrates that these immune adaptor proteins are phosphorylated on a 
conserved pLxIS motif (where p is a hydrophilic residue, and x is any nonaromatic amino 
acid) by TBK1, and that this interaction recruits IRF3 to the complex, leading to its 
phosphorylation and subsequent dimerization and nuclear translocation.  
While SA11-like NSP1 proteins do not contain an IκB-like degron, they do 
contain a motif reminiscent of the pLxIS motif found in MAVS, TRIF, and STING. 





Figure 5-1. Activation of immune adaptor proteins and IRF3. Adapted from Liu, et al. 
(237). Following detection of foreign RNA, DNA, or lipopolysaccharide, MAVS, 
STING, and TRIF activate IKK ad TBK1 kinases which subsequently phosphorylate 
these adaptor proteins on a conserved pLxIS motif. This phosphorylation recruits IRF3, 













Simian SA11-4F KNSGTLTEEFELLISNSEDDNE   
Simian SA11-5S KNSGT  
Simian RRV  EEEGKLSEEYELLISDSEDDD 
Human B4106 EEEGKLAEEYELLISDSEDDD 
Lapine 30-96 EEEGRLAEEYELLISDSEDDD 
Human Ro1845 EEEGKISEEYELLISDSEDDD 
Canine  K9  EEEGKISEEYELLISDSEDDDQ 
Equine L338  YEQGELSEEYELLISDSDGDE 
Equine FI14  EKQGKLSEEYDLLISDSDDD 
Murine ETD  QEHGDLAEEFDLLLSSSDSDED 
Bovine  UK  NKRNELIDEYDLELSDVE 
Human AK-13 NKRNDLMDEYSYELSDTE 
 
 
Figure 5-2. C-terminal alignment of SA11-like NSP1 proteins. SA11-like strains harbor a 
conserved motif reminiscent of the adaptor sequence pLxIS. All full-length NSP1 
proteins are proposed to interact with cullin-RING ligases via a conserved N-terminal 
RING domain, and to target host innate immune targets through a variable C-terminus. 
The conserved pLxIS motif occupies this location, much like phosphodegron motif of 















cellular immune adaptor proteins, we sought to evaluate the relevance of the pLxIS motif 
in the ability of NSP1 proteins to antagonize IRF3 signaling cascades. 
 
Materials & Methods 
Cells. Human embryonic kidney HEK293T cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS; Gibco), 2 mM 
glutamine, and 1,000 units per ml each of penicillin and streptomycin.  
 
Plasmids. The pLIC6 vector used for transient expression of wild-type and mutant forms 
of NSP1 has been described previously (138). Plasmids were grown in TOP10 
Escherichia coli cells (Thermo, Fisher), purified using NucleoBond Xtra endotoxin-free 
plasmid purification kits (Clontech), and verified by sequencing. Plasmids were modified 
using ligation independent cloning (LIC) as described in Morelli, et al. (138). Briefly, 
mutations were introduced by outward PCR of original plasmids with suitable primers, 
and ORFs were PCR amplified with LIC-compatible primers. PCR fragments were then 
gel purified and treated with T4 DNA polymerase in the presence of dATP to generate 
LIC sticky ends. The treated insert and digested pLIC6 were mixed, incubated at 25°C 
for at least 20 min, and transformed into Escherichia coli strain TOP10.  
 
Luciferase reporter assays. Transfection complexes (9.25 µl Opti-MEM, 92 ng pLIC6-
NSP1, 30 ng reporter construct, 3 ng pGL4.74[hRluc/TK] [Promega], 0.25 µl 
Lipofectamine 2000) were prepared in triplicate according to the manufacturer’s 
protocols and transferred to wells of a 96-well plate. An HEK293T cell suspension (90 
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ul; 1.1 × 106 cells/ml) was added to each well. Cells were treated at the time of 
transfection with 10 µg/ml poly(I:C) (Sigma), and incubated for 40 hours. At appropriate 
time points, cells were lysed in 20 µl 1× passive lysis buffer (Promega), and luciferase 
activity was assessed with the Dual-Glo luciferase assay system (Promega), according to 
the manufacturer’s instructions. Relative luciferase activity (NF-κB stimulation) was 
calculated by normalizing measured firefly activity to Renilla luciferase activity. Data 
(mean ± SD) are from one of three independent experiments. 
 
Statistical analysis. Prism v6.3f (GraphPad Software) was used to perform statistical 
analyses of independent experiments. Data were analyzed with one-way analysis of 
variance (ANOVA) using Dunnett’s multiple comparisons test. 
 
Results 
NSP1 proteins that encode a pLxIS motif inhibit IRF3 signaling. Work published by 
Liu, et al. demonstrates that interactions between IRF3 and innate immune adaptor 
proteins requires a pLxIS motif. By extrapolation, it was hypothesized that a similar 
motif within the C-terminus of NSP1 proteins may fulfill this requirement. To determine 
whether this motif has a role in IRF3 signaling inhibition, HEK293T cells were co-
transfected with NSP1 expression plasmids (Figure 5-2) and luciferase reporter constructs 
driven by wither IRF3 or TK promoters (Figure 5-3A, B). Transfected cells were 
stimulated with the cytokine TNF-α to induce IFN signaling cascades. The NSP1 
constructs included in this experiment either had pLxIS motifs within their c-termini 






Figure 5-3. Effect of NSP1 expression on IRF3 promoter activity.  
HEK293T cells were cotransfected with NSP1 and IRF3 firefly and HSV-tk Renilla 
luciferase reporters. Cells were stimulated at the time of transfection with 10 µg/ml 
poly(I:C). Relative luciferase activity was calculated at 40 h p.t. by normalizing firefly to 
Renilla luciferase activity. Samples were processed as part of two independent 
experiments. Data (mean ± SD from representative experiments performed in triplicate) 















































































UK). Only those NSP1 proteins lacking pLxIS motifs failed to inhibit IRF3 signaling 
when stimulated with TNF-α. This result supports the hypothesis that the pLxIS has a 
role in mediating IRF3 signaling during rotavirus infection. This finding is supported by 
the inclusion of the C-terminally truncated SA11-4F ΔC construct; that this NSP1 protein 
has reduced activity when compared to its full-length counterpart implicates a specific 
role for the pLxIS motif. Interestingly, both NSP1 proteins that failed to inhibit luciferase 
expression contained pLxIS > pLxLS mutations.  
 To further explore the role of the C-terminal pLxIS motif in innate immune 
antagonism, constructs to express mutant C-terminal truncations were generated for each 
of the NSP1 proteins included in the previous experiment. Each protein was truncated 
directly proximal to the pLxIS motif, as indicated in Figure 5-2 (red bar). As in Figure 6, 
HEK293T cells were co-transfected with plasmids to express mutant or WT NSP1 
proteins, in addition to luciferase expression constructs driven by an IRF3 or TK 
promoter. Compared to WT, most NSP1 proteins failed to inhibit IRF3 signaling when C-
terminally truncated. Ro1845 and K9, rotavirus strains of canine origin, retained their 
ability to antagonize IRF3 signaling when truncated (Figure 5-4A, B). This experiment 
supports a role for the pLxIS motif in NSP1 innate immune antagonism. Furthermore, the 
inclusion of NSP1 strains from diverse species origins, including simian, human, canine, 
and equine strains, suggests that this motif may be utilized by rotavirus NSP1 regardless 
of host or virus species.  
 
A terminal serine residue is not required for IRF3 antagonism. Liu, et al. found that 





Figure 5-4.  Effect of pLxIS truncations on NSP1-mediated IRF3 inhibition. 
HEK293T cells were cotransfected with wild-type or truncated NSP1 and IRF3 firefly 
and HSV-tk Renilla luciferase reporters. Cells were stimulated at the time of transfection 
with 10 µg/ml poly(I:C). Relative luciferase activity was calculated at 40 h p.t. by 
normalizing firefly to Renilla luciferase activity. Data (mean ± SD from one 












































































interactions between IRF3 and innate immune adaptor proteins. Additionally, Davis, et 
al. (148) recently published evidence demonstrating that OSU-like NSP1 proteins require 
phosphorylation of serine residues within a similar C-terminal motif to engage substrates 
within the NF-κB signaling cascade. Therefore, it was hypothesized that SA11-like NSP1 
proteins may also require phosphorylation prior to IRF3 binding. In order to evaluate the 
role of distinct residues within the pLxIS motif, plasmids to express mutant SA11-4F 
NSP1 proteins in which individual residues were changed to alanine were generated, 
including mutation of the terminal pLxIS serine residue, as well as a downstream 
proximal serine or glutamic acid residue. The ability of these mutant NSP1 proteins to 
antagonize IRF3 signaling was evaluated in HEK293T cells in which luciferase 
expression constructs had been co-transfected. Interestingly, each of these mutant SA11-
4F NSP1 proteins retained their ability to disrupt IRF3 signaling. This finding suggests 
that unlike what has been reported for OSU NSP1, no individual residue tested within the 
pLxIS motif governs the ability of NSP1 to engage IRF3. The absence of a required 
serine residue also suggests that phosphorylation within this region may not govern the 
activity of NSP1. This data does not exclude the possibility that the isoleucine residue 
affects binding; both UK and ETD NSP1s have an isoleucine > leucine substitution, and 
are inactive in this context (Figure 5-4B).  
 
Discussion 
 In this study, the role of a conserved, C-terminal pLxIS motif was evaluated in the 
ability of NSP1 to antagonize IRF3 signaling. Recent studies had identified pLxIS motifs 
within innate immune adaptor proteins MAVS, STING, and TRIF and demonstrated the 
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importance of this motif in the ability of these proteins to recruit the cellular kinase 
TBK1 and subsequently, cytoplasmic IRF3 transcription factors. These studies included 
biochemical, bioinformatic, and modeling techniques, and identified only residues within 
the pLxIS motif as contributing factors for target binding. Furthermore, it is intriguing 
that bound kinases serve two distinct purposes: first, to modify the immune adaptor 
protein, thus activating a motif for IRF3 interaction, and second, to efficiently modify 
bound IRF3 to swiftly activate without the need to form a secondary complex.  
 In the studies described here, we employed IRF3 promoter-driven dual luciferase 
assays to evaluate the ability of NSP1 proteins from numerous strains to antagonize 
signaling through this cascade. Including wild type, mutant, and truncated NSP1 proteins, 
these studies suggest that a conserved pLxIS motif is required for NSP1-mediated IRF3 
signaling disruption and innate immune evasion. This finding is similar to the 
requirements observed for IRF3 binding to its known cellular binding partners, 
suggesting that NSP1 proteins may have evolved to mimic the conserved motif found 
within MAVS, TRIF, and STING. While the pLxIS motif within cellular proteins is 
phosphorylated, our data suggests that this NSP1 motif is not modified prior to IRF3 
engagement.  
 Recently, Zhao, et al. (212) reported similar findings for SA11-like NSP1 
proteins. Their study, too, finds that a pLxIS motif is required for NSP1 to facilitate IRF3 
degradation, and show that phosphorylation is not required for this activity. They 
introduced the same S489A mutation and report that IFN-β promoter activity is 
unaffected, indicating that phosphorylation is not required. Furthermore, SPR binding 
data shows that NSP1 binding to IRF3 is unaffected by this change. Similar to our 
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assessment of defective ETD and UK NSP1 proteins, which include I486L mutations, 
Zhao, et al. report that an I488A mutation of SA11-4F NSP1 impairs IRF3 antagonism. 
Their modeling data suggest that both NSP1 and a phosphorylated NSP1 may bind IRF3 
substrates in a similar manner regardless of modification.  
 The elimination of a required phosphorylation event may be beneficial for NSP1, 
several-fold. Because NSP1 can engage IRF3 without first requiring engagement by 
TBK1, the virus is able to produce antagonistic proteins that are active from conception; 
there are no down stream steps required to activate these proteins, thus avoiding a 
potential limiting step. Furthermore, by specifically avoiding TBK1 modification or 
engagement requirements, NSP1 does not rely upon activation of innate immune 
signaling cascades for modification. This allows NSP1 to exert control over these 
signaling molecules prior to and independently of required detection by any PRRs. This 
finding is somewhat in contrast to the noted requirement of OSU-like NSP1 proteins and 
their reliance upon a CKII-mediated modification for activation. Perhaps, as is observed 
for MAVS, TRIF, and STING, in which the activating step is one of two required 
phosphorylation events, OSU NSP1 engagement with CKII precedes another as yet 
unidentified downstream phosphorylation event. Like SA11-4F, OSU NSP1 avoids the 
use of an immune-activated kinase responsible for phosphorylation of the protein it 
mimics, and these studies to not rule out the possibility that an as yet unidentified cellular 
kinase, perhaps a ubiquitously active kinase such as CKII, may modify SA11-4F NSP1 
and regulate its activity.   
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Part 3: Non-RVA NSP1 proteins have interferon antagonist activity 
Abstract  
 Rotavirus is a non-enveloped, segmented, double-stranded RNA virus that is 
responsible for significant gastrointestinal disease of both pediatric and veterinary 
concern. There are nine rotavirus species (RVA-RVI) currently recognized, of which 
RVA is responsible for the majority of infection in humans. To establish infection, a virus 
must initially circumvent the host innate immune response, and to combat this defense, 
RVA encodes at least two direct antagonists, NSP1 and VP3. RVA NSP1 is the product 
of genome segment 5 and mediates strain-specific degradation of cellular factors 
involved in the induction of interferon, a central innate immune effector whose 
expression established an antiviral stat in the infected cell. NSP1 proteins conserve key 
structural and functional domains within and between rotavirus species, and cluster 
according to host, supporting a role for NSP1 in host range restriction. RVA NSP1, the 
most variable member of the viral proteome, conserves an N-terminal putative RING 
domain and targets specific host proteins through a variable C-terminus. RVC, RVD, and 
RVF NSP1 proteins also conserve an N-terminal RING domain, suggesting that they may 
function utilized a similar mechanism. To understand how these non-RVA NSP1 proteins 
might antagonize host innate immunity, we examined their capacity to block interferon 
induction by targeting the NF-κB, IRF3, and JAK/STAT pathways. NF-κB, a 
transcription factor required for interferon induction, is activated by β-TrCP, a target of 
human and porcine RVA NSP1 activity. We have demonstrated that expression of RVD 
NSP1 prevents NF-κB activation, but unlike RVA NSP1, does not induce the degradation 
of β-TrCP. None of the tested NSP1 proteins affected IRF signaling, a frequent target of 
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animal-derived RVA strains. The precise mechanism of action of these NSP1 proteins 
remains to be elucidated, and interestingly, we did not identify any targets of RVC or 
RVF NSP1 activity. Further exploration of critical protein domains and potential targets 
will shed light on the novel innate immune evasion strategy employed by non-RVA 
NSP1 proteins.  
 
Introduction 
 While significant strides have been made in delineating the approach and 
mechanisms employed by Group A rotaviruses to disrupt immune responses and 
interferon induction, much less is known about NSP1 proteins from non-Group-A strains. 
Rotavirus Group C (RVC) are a pathogenic agent of piglets and adult pigs, and are 
sometimes found in adult humans, although human infections are often asymptomatic 
(238). Rotavirus Group D and Group F (RVC, RVF) are frequently found in avian 
species (239). These viral strains are difficult to culture in lab settings, and the associated 
hurdles have been difficult to surpass. However, the publication of whole genome 
sequences from viruses recovered from infected animals has improved accessibility in 
recent years (240).   
While RVA NSP1 proteins have known roles in control of interferon and antiviral 
responses, the role of NSP1 proteins from non-Group A rotaviruses in viral innate 
immune antagonism is less clear. The activity of NSP1 proteins from RVC, RVD, and 
RVF strains has not been evaluated. Based on sequence homology, it is likely that these 
proteins share a domain composition and organization similar to what has been reported 




Figure 5-5. Non-Group A NSP1 predicted structural architecture, adapted from Morelli, 
et al. (115). (A) RVC, RVD, and RVF NSP1 proteins retain structural elements common 
to RVA NSP1 proteins, including a putative RING domain (gold). RVD NSP1 shares in 
common with avian RVA NSP1 proteins a domain of the transcription factor IIE alpha 
subunit (red). (B) The putative RING domains from RVA, RVC, RVD, and RVF NSP1 














characterized as having three key domains: a N-terminal, RNA-binding putative RING 
domain (Figure 5-5B); a cytoskeleton-localization domain; and a C-terminal targeting 
domain. This same organization has been predicted for RVC, RVD, and RVF NSP1 
proteins, using sequences from Bristol, 05V0049, and 03V0568 strains respectively, and 
thus these strains are sometimes referred to as having an Group A-like classification (115, 
241, 242).  While it is markedly shorter, RVC NSP1 is most closely related to Group A 
proteins (243). RVD NSP1 proteins are closely related to Group A avian NSP1 proteins, 
but these proteins contain an additional domain with TFIIE (Transcription Factor II E) 
homology, suggesting nucleic acid binding activity, that is not found in other NSP1 
proteins.  
 Despite differences that appear between rotaviruses that have divergent host 
speciation, it has long been supported that diverse rotavirus lineages may serve promising 
roles as attenuated vaccine strains (244). However, widely utilized vaccines of either 
reassortant origin, while highly efficacious in developed countries, fail to protect to the 
same degree in developing regions of the world. To this end, it will be valuable to further 
explore how existing strains interact with innate immune responses. In this study, we 
sought to evaluate the role of NSP1 from RVC, RVD, and RVF viruses in immune 
antagonism and interferon induction.  
 
Materials & Methods 
Cells. Human embryonic kidney HEK293T cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS; Gibco), 2 mM 
glutamine, and 1,000 units per ml each of penicillin and streptomycin.  
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Plasmids. RVC (Bristol), RVD (05V0049), and RVF (03V0568) NSP1 sequences were 
synthesized by GenScript and cloned into PLIC6 expression vectors, as described in 
Morelli, et al. (138). Plasmids were generated in TOP10 Escherichia coli cells (Thermo, 
Fisher) and purified using an NucleoBond Xtra endotoxin-free plasmid purification kit 
(Clontech). All sequences were verified by sequencing.  
 
Luciferase reporter assays. Transfection complexes (9.25 µl Opti-MEM, 92 ng pLIC6-
NSP1, 30 ng reporter construct [NF-κB, Promega; IRF3, Marrio Barro], 3 ng 
pGL4.74[hRluc/TK] [Promega], 0.25 µl Lipofectamine 2000) were prepared in triplicate 
in compliance with the manufacturer’s protocols and as described (Morelli mBio) and 
incubated in wells of a 96-well plate. HEK293T cells in DMEM (90 ul; 1.1 × 
106 cells/ml) were added to each well. For NF-κB experiments, cells were treated for 4 h 
at 24 h p.t. in medium with 25 ng/ml TNF-α (PeproTech). For IRF3 experiments, cells 
were treated with 10 ug/ml poly(I:C) (Sigma) at the time of transfection and incubated for 
40 hours. At appropriate specified points, cells were lysed in 1× passive lysis buffer 
(Promega) (20 µl), and luminescence was assessed with the Dual-Glo luciferase assay 
system (Promega), according to the manufacturer’s instructions. The relative luciferase 
activity (NF-κB or IRF3 stimulation) was calculated by normalizing firefly luciferase 
activity to Renilla luciferase activity. Data (mean ± SD) are from one representative 
independent experiment. 
 
Immunoblot assay. Trasnfection complexes (94 µl Opti-MEM [Gibco], 500 ng pLIC6-
NSP1, 500 ng pLIC6F-β-TrCP, 2 µl Lipofectamine 2000 [Life Technologies]) were 
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prepared according to the manufacturer’s protocols and transferred to wells of a 12-well 
plate. A HEK293T cell suspension (900 µl; 1.3 × 106 cells/ml) was added to each well. 
At 24 h p.t., cells were collected, washed once with phosphate-buffered saline (PBS 
[pH 7.4]), and lysed in a 100-µl solution of 1× radioimmunoprecipitation assay (RIPA) 
buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 1% Nonidet P-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate), 1× NuPAGE lithium dodecyl sulfate (LDS) 
sample buffer (Life Technologies), 25 mM dithiothreitol, 1× phosphatase inhibitor 
cocktail (1 mM each sodium fluoride, sodium orthovanadate, β-glycerophosphate, and 
sodium pyrophosphate), and 1× Complete EDTA-free protease inhibitor cocktail 
(Roche). Lysates were briefly sonicated, denatured by heating to 70°C, and 
electrophoresed on 10% Tris-Glycine gels (Invitrogen). Samples were transferred onto 
nitrocellulose membranes using an iBlot apparatus (Thermo, Fisher). Membranes were 
blocked by incubation in Blotto Solution (Thermo, Fisher) prior to incubation with 
primary antibody diluted in PBST (PBS with 0.02% Tween) with 5% milk solution. 
Membranes were washed with PBST before incubating with fluorophore-conjugated 
secondary antibody diluted in milk-PBST solution. Membranes were imaged on an 
Odyssey Classic and quantified using Image Studio Lite v3.1.4 (LI-COR Biosciences). 
Bands of interest were normalized to the loading control, PCNA. 
 
Statistical analysis. Prism v6.3f (GraphPad Software) was used to perform statistical 
analyses of independent experiments. Data of each experiment were analyzed with one-





RVC, RVD, and RVF NSP1 proteins contain neither an IRF- nor a β-TrCP-
targeting domain. NSP1 proteins differentially antagonize host signaling pathways in a 
manner that is often directly associated with C-terminal sequences and the presence of 
conserved interaction motifs (137). Minimally, these NSP1 interaction motifs can be 
characterized as indicative of IRF3 or β-TrCP binding, as has been observed for SA11-4F 
and OSU NSP1. To predict the activity of RVC (Bristol), RVD (05V0049), and RVF 
(03V0568) NSP1 proteins, the Eukaryotic Linear Motif resource (elm.eu.org) was used to 
identify potential binding sites. This effort was focused on sequences within the C-
terminus of the protein, where Group A rotaviruses harbor the majority of their 
interaction motifs. This analysis indicated the absence of any known relevant binding 
sites within the NSP1 proteins tested. However, while interaction motifs of mammalian 
IRF3 and NF-κB have been well characterized, less is known about the avian homologues 
of these proteins. Accordingly, this analysis does not rule out the possibility that an 
alternative motif mediates interactions with these proteins in chickens. Notably, RVD 
contained a pLxIS motif at resides 244-249 (TLDIS), but the location of this motif within 
the globular center of the protein makes it an unlikely candidate in IRF3 antagonism. 
These findings suggest that RVC, RVD, and RVF NSP1 proteins may target host 
signaling pathways in a manner that is different than what has been described for RVA 






Figure 5-6. Effect of NSP1 expression on NF-κB activation.  
Like OSU NSP1, RVD antagonizes NF-κB activation. HEK293T cells were cotransfected 
with NSP1 and NF-kB firefly and HSV-tk Renilla luciferase reporters. At 24 h p.t., cells 
were stimulated for 4 h with 25 ng/ml TNF-a. Relative luciferase activity was calculated 
















































RVD NSP1 disrupts NF-κB signaling. Despite the lack of any detectable substrate 
interaction motifs, we sought to experimentally evaluate whether RVC, RVD, or RVF 
were antagonists of canonical NSP1 target signaling cascades. Expression constructs 
containing NSP1 ORFs of each NSP1 were generated as described previously (138). To 
evaluate the capacity of non-Group A NSP1 proteins to block NF-κB activation, 
HEK293T cells were co-transfected with NSP1 and NF-κB luciferase reporter constructs. 
In addition to non-RVA NSP1 proteins, the well-characterized NSP1 proteins from 
simian SA11-4F and porcine OSU strains were included (Fig. 5-6). These NSP1 proteins 
are known antagonists of IRF3 and NF-κB signaling, respectively, and do not possess the 
ability to target both respective pathways. In addition to OSU NSP1, RVD NSP1 
markedly inhibited NF-κB promoter activity, but SA11-4F, RVC, and RVF NSP1 
proteins did not reduce activation compared to empty vector or mock transfected cells. 
RVD NSP1 lacks a known DSGIS motif that regulates interaction between OSU NSP1 
and β-TrCP, so this data suggests that an alternative mechanism may be employed by 
RVD NSP1 to disrupt promoter activation. 
OSU NSP1 primarily disrupts NF-κB signaling cascades by facilitating 
proteasomal degradation of β-TrCP. However, OSU NSP1 may possess the ability to 
inhibit β-TrCP by simply binding, without necessarily inducing degradation (148). To 
evaluate whether RVD NSP1 similarly facilitates proteasomal degradation of β-TrCP, 
constructs to express RVD NSP1 and FLAG-tagged β-TrCP were co-transfected into 
HEK293T cells. The level of β-TrCP was assayed 24 h p.t. by quantitative immunoblot 
using anti-FLAG antibodies. As indicated in Fig. 5-7A, RVD NSP1 expression had no 







Figure 5-7. Quantification of NSP1 protein ability to facilitate degradation of β-TrCP or 
IRF3. HEK293T cells were cotransfected with NSP1 and (A) FLAG-β-TrCP or (B) 
FLAG-IRF3. At 24 h p.t., proteins were assayed by immunoblot. Intensity of anti-FLAG 



























































in the presence of RVD NSP1, no degradation was observed (Fig. 5-7B). This data 
suggests that RVD NSP1 inhibits NF-κB activation without also facilitating degradation 
of β-TrCP, and likely has no effect on IRF3 signaling cascades.  
 
Neither RVC, RVD, nor RVF NSP1 restrict IRF3-mediated interferon induction. 
Because both NF-κB and IRF3 signaling cascades are important for the induction of 
interferon in chickens, we next investigated the ability of non-RVA NSP1 proteins to 
inhibit IRF3 signaling cascades. RVD NSP1 does not contain a canonical β-TrCP 
targeting domain, and yet our data show that this protein possesses the ability to 
antagonize NF-κB signaling cascades. By extrapolation, it is possible that RVC, RVD, 
and RVF NSP1 proteins that do not contain canonical IRF3 targeting domains may also 
retain the ability to antagonize this signaling cascade. To evaluate this possibility, 
constructs to express individual NSP1 proteins were co transfected with an IRF3-driven 
luciferase reporter construct in HEK293T cells. While SA11-4F proteins sufficiently 
inhibited activation of the ISRE promoter, both SA11-5S and OSU NSP1 proteins were 
unable to disrupt this signaling cascade (Fig. 5-8). Similarly, RVC, RVD, and RVF NSP1 
proteins did not inhibit ISRE activation. This data suggests that RVC, RVD, and RVF 
NSP1 proteins do not inhibit interferon induction by targeting IRF3 proteins, but this 
experiment does not rule out the possibility that they may behave differently in a non-





Figure 5-8. Effect of non-RVA NSP1 expression on IRF3 activation. Only SA11-4F 
NSP1 inhibits IRF3 signaling and ISRE activation. HEK293T cells were cotransfected 
with NSP1 and ISRE firefly and HSV-tk Renilla luciferase reporters. At 48 h p.t., cells 
were stimulated for 4 h with 10 ug/ml poly(I:C). Relative luciferase activity was 














































RVD NSP1 antagonizes JAK/STAT signaling. Thus far, our data does not present a 
strong role for these non-RVA NSP1 proteins in inhibition of interferon induction. Thus, 
in addition to the canonical IRF3 and NF-κB signaling cascades, we expanded our 
analysis to include paracrine and autocrine cascades. Cytokines released from activated 
cells to bind interferon receptors on its own surface (autocrine) or on a neighboring cell 
(paracrine) to amplify antiviral responses. This response activates the Janus kinase (JAK) 
and activator of transcription (STAT) pathway to induce interferon and interferon-
stimulated genes. Activated JAK and TYR kinases phosphorylate STAT1 and STAT2, 
which in turn, assemble with IRF9 to form the ISGF3 (Interferon Stimulated Gene Factor 
3) complex, which binds ISRE promoters in the nucleus to induce interferon (245). NSP1 
proteins from the human strain Wa and the simian strain RRV are know in inhibit nuclear 
translocation of STAT proteins (246).  To assess the possible role of non-Group A NSP1 
proteins in JAK/STAT signaling, NSP1 expression plasmids were co-transfected into 
HEK293T cells with ISRE-driven luciferase constructs. Following treatment with 
Poly(I:C), only RVD NSP1 was able to inhibit JAK/STAT activation (Fig. 5-9). Neither 
OSU, SA11-4F, SA11-5S, RVC, nor RVF NSP1 proteins reduced activation below levels 
observed in vector- or mock-treated cells. NSP1 proteins from OSU and RVC strains 




Figure 5-9. Effect of non-RAV NSP1 expression on JAK/STAT activation. RVD NSP1 
inhibits JAK/STAT signaling. HEK293T cells were cotransfected with NSP1 and STAT 
firefly and HSV-tk Renilla luciferase reporters. At 4 h p.t., cells were stimulated with 


















































 In the present study, we evaluated the ability of non-Group A NSP1 proteins to 
interfere with signaling cascades known to be common targets for Group A NSP1 
proteins. These pathways included pro-interferon activation pathways mediated by IRF3, 
NF-κB, and JAK/STAT. In dual luciferase assays, RVC and RVF NSP1 proteins failed to 
interfere with either IRF3 or NF-κB promoter activity, suggesting that they do not have 
the same activity as known classes of RVA NSP1 proteins. Interestingly, RVC NSP1 
expression appeared to increase activation of both JAK/STAT and IRF3 signaling 
cascades. RVD NSP1, however, was found to inhibit activation of JAK/STAT and NF-
κB signaling, and did so without facilitating degradation of either β-TrCP or IRF3. 
Expression of interferon β mRNA was not directly assessed in these experiments, but this 
data collection represents the first evidence that non-RVA NSP1 proteins may possess the 
ability to inhibit interferon induction cascades. 
While NSP1 proteins are notoriously diverse with little sequence conservation 
between rotavirus groups and species, most NSP1 proteins conserve the N-terminal 
RING domain. Available NSP1 sequences primarily belong to viruses within group A, 
rotaviruses responsible for the majority of human disease. Non-RVA rotavirus strains 
have been identified as major disease causing pathogens in a number of non-human host 
species, but very few studies have been published describing the pathogenesis or 
molecular biology of these strains. These RVD and RVF virus groups are found avian 
species, while RVC causes infection in pigs, but only RVC is known to infect humans. 
Few sequences are available for non-Group A NSP1 proteins, but current analysis 
suggests that NSP1 proteins from RVC, RVD and RVF cluster with RVA sequences in 
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an RVA-like functional class (115). Furthermore, sequencing data suggests that these 
NSP1 proteins, like Group A NSP1 proteins, contain an analogous putative RING domain 
with similar spacing and predicted architecture: C-X2-C-X8-C-X2-C-X3-H-X-C-X2-C-X4-
7-C. While earlier reports define an RNA binding role for this region of the protein, more 
recent studies suggest a second biological role for this sequence conservation in 
mediating interactions with hijacked CRLs (148). This finding also points towards a 
shared mechanism governing NSP1 activity despite target protein identity or host species.  
While non-RVA NSP1 proteins contain no readily identifiable targeting domains 
within their C-termini, as has been observed for RVA strains such as OSU and SA11-4F, 
it is possible that these proteins utilize as yet unidentified motifs within these regions 
towards this goal. While there appears to be little sequence variation in dimerization 
domains of IRF proteins specifically (237), diversity does exist in innate immune 
response proteins across species. Chickens, for example, do not encode a RIG-I protein 
(247), and thus are much more susceptible to avian influenza viruses to which ducks are 
resistant. RIG-I, too has been identified as a crucial PRR in mediating immune responses 
to rotavirus infection, so it is intriguing that RVD rotaviruses, an avian pathogen, has 
evolved to antagonize signaling cascades down stream of RIG-I activation. As individual 
pathogens evolve with a specific host, it is expected that their respective approach 
towards interferon antagonism may also narrow. It will be intriguing to examine the 
ability of non-human pathogens, such as RVD, RVC, and RVF rotaviruses, to antagonize 
immune responses across a panel of host species. Clearly, additional research is needed to 
fully evaluate the approaches utilized by the NSP1 proteins of these viruses, and to 
establish how they diverged evolutionarily with individual hosts. 
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Part 3: OSU rotavirus infection affects mTOR signaling through DEPTOR 
accumulation  
Abstract  
 The F-box adaptor protein β-TrCP is responsible for specifying ubiquitination 
substrates of the cullin-RING ligase SCFβ-TrCP (Skp1-Cul1-F-box). This process leads to 
directed proteasomal degradation of specific substrate proteins, and helps to regulate the 
stability of proteins involved in regulating a vast number of cellular pathways. These 
pathways are involved in cell cycle progression, innate immune response, as well as 
aspects of cell fate and survival. While many viruses are known to target β-TrCP and its 
activity as a means of inhibiting interferon expression, increasingly evidence suggests 
that β-TrCP control may provide added benefits to viruses, shaping an intracellular 
environment that promotes viral replication from a number of angles. To this end, we 
addressed whether rotavirus infection by the OSU strain resulted in observable changes in 
signaling of pathways under β-TrCP control, in addition to NF-κB and interferon 
expression. We found that in multiple cell types, OSU infection results in increased levels 
of DEPTOR, an mTOR-associated protein that promotes autophagy. The constellation of 
mTOR associated proteins detected during rotavirus infection suggest that infected cells 
adopt a state of extended autophagy, and this intracellular environment may represent a 
generally pro-viral milieu promoted by the activities of diverse viral proteins from both 







 The mechanism by which human and porcine NSP1 proteins target β-TrCP for 
degradation has been well described by several groups, and the role of this protein as an 
interferon antagonist has been strongly established (137, 138, 148). β-TrCP, however, has 
roles that extend far beyond control of NF-κB signaling and modulation of innate 
immune responses (248-252). While many publications exist describing control of this 
protein by viruses in diverse families, including HIV, Epstein Barr, and vaccinia viruses 
(150, 151), few studies have been published describing the impact of virus-altered β-
TrCP activity on regulation of other cellular pathways.   
 β-TrCP functions as an F-box containing adaptor protein of cellular E3 ubiquitin 
ligases from the cullin-RING family (CRLs). Specifically, β-TrCP binds CRLs 
containing a cullin 1 (Cul1) scaffold protein, termed SCFβ-TrCP after its critical 
components (Skp1-Cul1-F-box). As an integral component of the ubiquitin proteasome 
pathway, this protein complex targets proteins for ubiquitination and subsequent 
degradation. Substrate targeting is specified by β-TrCP adaptor proteins, and binding is 
mediated by affinity for a preferred phosphodegron sequence, DpSDGxxpS. Variations of 
this phosphodegron exist, typically with an insertion or deletion between phospho-serine 
residues. Human and porcine NSP1 proteins, for example, encode a conserved DSGIS 
phosphodegron sequence that is also found in cellular targets of β-TrCP, such as Nrf2, 
EpoR, and CREB-H (253-255).  
 Intriguingly, several known substrates of β-TrCP directly affect cell survival 
pathways, including DEPTOR (DEP-domain containing mTOR-interacting protein) 
(256), a negative regulator of mTOR signaling (257). As an mTOR inhibitor, DEPTOR is 
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involved in control of cellular homeostasis by regulating apoptosis and autophagy, 
however its complete role has not been defined. Furthermore, data suggests that 
DEPTOR can behave as either a negative or positive regulator of cell death, depending 
on cell and tissue contexts (257). DEPTOR exists in both mTORC1 and mTORC2 
complexes, and when bound, inhibits mTOR kinase activity (258). Additionally, both 
DEPTOR and mTOR negatively regulate each other; DEPTOR downregulation increases 
mTOR activity, in turn, further reducing levels of DEPTOR. Active mTORC1 is highly 
reactive to intra- and extra-cellular stimuli, including growth factors and oxygen, by 
phosphorylating 4EBP1 and p70-S6K, leading to protein and lipid synthesis. Inhibition of 
mTORC1 leads to an apparent increase in mTORC2 signaling, leading to Akt 
phosphorylation, promoting cell survival pathways (257). The Akt pathway is highly 
active in some cancers, and its downstream targets are associated with proliferation (259) 
and the inhibition of apoptosis (260).  
Because of its role in cell survival and because DEPTOR is regulated by β-TrCP 
activity, we assessed the impact of rotavirus infection on DEPTOR stability, and 
subsequent regulation of mTOR substrates. In this study, we found that DEPTOR levels 
increased during OSU infection, but not during infection with the bovine strain UK or 
with TNF-α activation. Analysis of mTORC1 and mTORC2 substrates, including Akt, 
4E-BP1, and p70-S6, suggest that OSU infection results in preferential inhibition of 
mTORC1, while supporting mTORC2 activation and pro-survival signaling. This study 
supports a role for NSP1 as a regulator of intracellular environments resulting in a pro-




Materials & Methods 
Cells and viruses. Human colorectal HT29 cells were grown in McCoy’s 5A (modified) 
medium containing 10% fetal bovine serum (FBS) (Gibco) and 1,000 units/ml penicillin-
streptomycin. African green monkey fetal kidney (MA104) cells were grown in Medium 
M199 containing 10% FBS and penicillin-streptomycin. Rotaviruses were propagated 
and titered by plaque assay on MA104 cells as described previously (221). Prior to 
infection, rotaviruses were activated by treatment with 5 µg per ml of porcine pancreas 
trypsin (type IX-S; Sigma-Aldrich) for 1 h at 37°C. 
  
Antibodies. Rabbit polyclonal antibodies to viral proteins (simian SA11-4F VP6 protein, 
porcine OSU NSP1 protein) (137) and PCNA (Santa Cruz Biotech [SCB], sc-7907), 
DEPTOR (SCB, sc-398169) and p-IκB (Cell Signaling Technology [CST], #9246) were 
used at 1:5,000 dilution. Antibodies to 4E-BP1 (CST, #9452), p-4E-BP1 (CST, #2855), 
Akt (CST, #4691), p-Akt (CST, #9271), mTOR (CST, #2983), p70-S6K (CST, #2708), 
and p-p70-S6K (CST, #9234) were used at a 1:1000 dilution. HRP-conjugated goat anti-
rabbit IgG antibody (CST, #7074) and horse anti-mouse IgG antibody (CST, #7076) were 
used at 1:10,000 dilution. 
  
Inhibitors. The protein kinase CKII inhibitor, 4,5,6,7-tetrabromobenzotriazole (TBB) 
(Tocris Bioscience) and the small molecule inhibitor of CRL neddylation, MLN4924 
(Cayman Chemical), were prepared as 1 mM stocks in dimethyl sulfoxide (DMSO), 
which were stored at -20°C. TBB and MLN4924 were diluted in cell culture medium to 
final concentrations of 80 and 1 µM, respectively, immediately prior to use. TNF-α 
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(Sigma) was dissolved in water at a concentration of 25 mg/ml and diluted in media to a 
final concentration of 25 ng/ml.  
  
Viral infection. Near confluent monolayers of HT29 cells in 6-well tissue-culture plates 
were infected at an MOI of 5 with trypsin-activated rotavirus. After adsorption for  one-
hour, the virus inoculum was removed and cell monolayers were rinsed once with PBS. 
Monolayers were then incubated in serum-free McCoy’s 5A (modified) or M199 medium 
until 8 h p.i. Lysates were prepared by washing monolayers with cold PBS and scraping 
cells into 0.25 ml lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% Triton X-
100, with 1× Complete EDTA-free protease inhibitor cocktail). Lysates were incubated 
on ice for 30 min, gently mixed, and clarified by centrifugation for 10 min at 15,000 x g 
at 4°C. 
 
Immunoblot assay. Protein samples were mixed with NuPAGE LDS sample buffer 
(Invitrogen) with 50 mM dithiothreitol (DTT), and denatured by heating to 70°C (10 
min). Proteins were resolved by electrophoresis on pre-cast 10% Tris-glycine 
polyacrylamide gels (Novex). Molecular weight markers (EZ-Run, Fisher Scientific) 
were resolved in parallel to determine protein sizes. Proteins were transferred from gels 
onto nitrocellulose membranes using an iBlot dry transfer apparatus (ThermoFisher) 
according to the manufacturer’s instructions. Membranes were blocked by incubating in 
5% BSA dissolved in TBS-0.1% Tween-20 (TBST) prior to incubation with primary 
antibody diluted in BSA-TBST solution. Membranes were washed with TBST before 
incubating with HRP-conjugated secondary antibody diluted in BSA-TBST solution. 
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Membranes were washed with TBST and developed using Super Signal West Pico 
chemiluminescent substrate (Pierce). Immunoblots were imaged using the Azure Series 
c500 Infrared Imaging System. 
 
Results 
DEPTOR levels increase during OSU infection. To assess whether rotavirus infection 
influenced DEPTOR stability, infected cell lysates were assayed for the presence of 
DEPTOR proteins (Fig. 5-10). DEPTOR is a target of β-TrCP, and accordingly, a 
rotavirus strain that encodes an NSP1 capable of facilitating inhibition and proteasomal 
degradation of β-TrCP was chosen. HT-29 cells were infected with the porcine rotavirus 
strain OSU, or mock infected, and harvested every 2 h to 10 h p.i. By immunoblot 
analysis, DEPTOR levels in infected cells appeared to increase, and reach peak levels by 
10 h p.i. This time point correlated with observable β-TrCP degradation (148). No 
DEPTOR was detected in mock-infected cells, or at early time points during infection. 
This data suggests that β-TrCP inhibition and degradation by NSP1 may facilitate 
accumulation of DEPTOR during rotavirus infection.  
 
OSU-dependent DEPTOR accumulation correlated with viral replication. To further 
assess the association between rotavirus infection and DEPTOR accumulation, we 
addressed whether an increase in cellular DEPTOR levels was a result of interferon 
induction or activation of pro-inflammatory responses. To test this hypothesis, MA104 
cells were infected with OSU or treated with TNF-α. Cell lysates were prepared and 





Figure 5-10. Accumulation of DEPTOR during OSU infection. HT29 cells were OSU- or 
mock-infected (MOI of 5) and harvested at 2 h intervals to 10 h p.i. Lysates were 
resolved by electrophoresis and transferred to nitrocellulose membranes. Blots were 

























































Figure 5-11. Effects of drug treatment on DEPTOR accumulation. MA104 cells were 
OSU- or UK- infected at an MOI of 5, or treated with TNF-a, and harvested at 8 h p.i. 
Lyastes were resolved by electrophoresis and transferred to nitrocellulose membranes for 











protein levels following OSU infection, but not when cells were treated with TNF-α (Fig. 
5-11). This result indicates that DEPTOR accumulation is likely a direct result of 
rotavirus infection. DEPTOR is a highly variable protein in that it is over expressed in 
some cancer cells and under expressed in others; that OSU infection resulted in increased 
DEPTOR levels in both human HT-29 colorectal cancer cells and simian MA104 kidney 
cells suggests that OSU induction of DEPTOR may not be a cell-line specific result. 
Interestingly, MA104 cells infected with the bovine UK virus did not induce DEPTOR 
accumulation. UK NSP1 proteins have only mild effects on β-TrCP stability, when 
compared to results obtained with OSU NSP1 proteins, which may account for this 
discrepancy.  
 To examine the role of NSP1 function on DEPTOR accumulation, protein levels 
were assessed in infected or TNF-α-treated cells following treatment with TBB or MLN 
(Fig. 5-11). NSP1 requires dual phosphorylation mediated by CKII to facilitate binding to 
β-TrCP; TBB is a small molecule inhibitor of CKII, thus inhibiting NSP1-β-TrCP 
interactions (148). MLN is a Nedd8 activating enzyme inhibitor that inhibits activation of 
assembled CRLs, preventing proteasomal degradation of CRL targets, such as β-TrCP 
(148). Compared to OSU-infected cells treated with DMSO, TBB reduced DEPTOR 
accumulation in OSU-infected cells. As measured by levels of VP6, OSU viral 
replication decreased in the presence of TBB. The observed decrease in DEPTOR levels 
may be due to compromised NSP1 activity, but we cannot rule out the possibility that 
DEPTOR levels are affected by a decrease in viral replication. MLN treatment appeared 
to have no effect on DEPTOR accumulation in OSU infected cells, but did affect levels 
of p-IκB, a protein that is rapidly degraded by CRLs when β-TrCP is functional.   
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Figure 5-12. Effects of drug treatment and viral infection on mTOR signaling proteins. 
MA104 cells were OSU- or UK- infected at an MOI of 5, or treated with TNF-a, and 
harvested at 8 h p.i. Lyastes were resolved by electrophoresis and transferred to 
nitrocellulose membranes for immunoblotting with antibodies specific for mTOR, p70-









Next, because rotavirus infection appears to affect DEPTOR levels, we assessed the 
impact of OSU or UK infection on autophagy by assessing markers of mTOR signaling. 
We included assessments of substrate proteins known to be markers of either mTORC1 
and mTORC2 activity. p70-S6K is a substrate of active mTORC1 whereas Akt 
is a substrate of mTORC2. Active p-Akt is often associated with inhibition of mTORC1.  
While total levels of mTOR did not change upon infection with OSU or UK strains, or 
with TNF-α treatment, phosphorylation of p70-S6K increased during viral infection 
compared to TNF-α treatment, although to a lesser extent in the presence of UK 
compared to OSU (Fig. 5-12). p-Akt also increased during infection, and like p70-S6K, 
more p-Akt was observed during OSU infection compared to UK. Phosphorylation of 
both p70-S6K and Akt was inhibited in the presence of TBB, but our results cannot 
resolve whether this is a direct result of TBB, or if it is instead due to the TBB-mediated 
failure to activate NSP1 proteins. Together, this data suggests that rotavirus infection 
results in activation of mTORC1 and mTORC2, with stronger effects observed during 
OSU infection compared to the UK strain. Our results describe the balance of mTOR 
signaling at only a single time point during viral infection; these signaling cascades are 
highly dynamic and may be regulated differently at other time points. 
  To further examine the role of rotavirus infection on cell survival pathways, we 
assessed the effect of infection by OSU and UK on Akt signaling. Both OSU and UK 
infection resulted in increased levels of p-Akt, and to assess the activity of this protein, 
we examined levels and modification of 4E-BP1, a substrate of p-Akt. 4E-BP1 negatively 
regulates protein synthesis and can be inhibited by Akt-mediated phosphorylation. In 
these experiments, we observed no change in p-4E-BP1 levels, however, 4E-BP1 levels 
 
 135 
appeared to increase with TBB treatment for UK-infected and TNF-α-treated cells, 
whereas levels remained low in TBB-treated OSU-infected cells.  
 
Discussion 
 Rotavirus infection results in cell death and release of nascent virions through cell 
lysis. Activation of cell death pathways late in infection benefits spread of viral infection 
due to release of mature particles, but viral control of cell fate earlier in infection may 
benefit the pathogen by inhibiting premature cell death. To this end, little is known about 
how rotavirus may affect apoptosis or autophagy pathways, and if control of mTOR 
pathways is implicated in these activities. In these experiments, we have shown that 
infection with β-TrCP targeting rotavirus strains results in accumulation of DEPTOR, an 
mTOR regulatory protein, and that infection results in marked activation of mTORC1, 
mTORC2, and Akt signaling.  
mTOR signaling and the balance between mTOR and Akt is somewhat 
paradoxical (261). It has been proposed that activities of each complex require 
inactivation of other components, as has been suggested for mTORC1 and mTORC2. 
Inactivation of mTORC1 can promote to the constitution of mTORC2, leading to 
phosphorylation of Akt. Activation of Akt is associated with active mTORC2 and 
inactive mTORC1 (262), however p-Akt can in turn increase the activity of mTORC1 in 
a negative feedback cycle. Activation of Akt promotes cell survival and activates 
autophagy, and this protein can be alternatively activated by TBK1 (263). It is not clear 
how individual activities are partitioned, and the complete network by which each 
signaling cascade influences the others.  
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 A recent assessment of autophagy pathways during influenza infection has lead 
to the proposal of a mechanism for viral control of expanded, lethal autophagy signaling 
cascades (264).  Autophagy is activated during influenza infection, and helps avoid 
triggering apoptosis. In the absence of apoptosis, cells are described as undergoing a 
vastly expanded autophagy process. In this terminal autophagy cascade, activity of 
mTOC1, PI3K, and mTORC2 increase, as observed in highly phosphorylated p70-S6K 
populations that are regulated by mTORC2. Similar to our results, Datan, et al. also show 
an increase in p-Akt without changes to mTOR populations. Through timecourse analysis 
they demonstrate a more intricate network of how these pathways co-regulate one 
another. This signaling pattern is described as altered mTOR/p70-S6K signaling, and 
occurs during expanded lethal autophagy; inhibition of this process vastly decreases 
influenza titer.  
 Continued research is required to assess the complete functional role that 
autophagy signaling plays during rotavirus infection, and specifically, how the activity of 
NSP1 proteins may direct signal transduction through these cascades. The PI3K-Akt-
mTOR axis has recently been reported to be an essential signaling cascade during 
rotavirus infection (265). Yin, et al. describe inhibition of viral replication achieved by 
rapamycin treatment, however the precise mechanism that the virus uses to harness this 
signaling cascade to its own advantage is not described. Our identification of an axis 
drawing from NSP1 activity through β-TrCP signaling and DEPTOR stability presents a 
novel mechanism of viral control. Our assessment is a single step towards describing 



























Viruses have evolved a vast set of complex approaches towards regulating innate 
immune responses, and yet, a surprising number of these approaches hinge upon altering 
the activity of a single protein: β-TrCP. β-TrCP is a key regulator of NF-κB signaling, 
and by facilitating degradation of IκB, the inhibitor of NF-κB, promotes NF-κB nuclear 
translocation and interferon induction. To this end, most human and porcine rotavirus 
strains encode NSP1 proteins capable of binding β-TrCP, inhibiting interferon induction 
and regulation of other β-TrCP substrates. NSP1 acts as a substrate adaptor protein of 
cellular CRLs, and by bridging both β-TrCP and a CRL, the protein facilitates 
proteasomal degradation of its β-TrCP target. Additional evidence supports the 
hypothesis that while observable β-TrCP degradation remains the gold standard in NF-κB 
inhibition, binding by NSP1 may be sufficiently inhibitory. Inhibition of β-TrCP has 
clear implications in regulation of interferon induction pathways; however, β-TrCP 
controls the stability of additional targets beyond IκB. That viruses co-opt control of this 
protein suggests there may be far reaching implications of β-TrCP activity that affect the 
intracellular environment to support productive viral replication.  
In our studies of NSP1 function, we first sought to establish the determinants of β-
TrCP-NSP1 binding and to identify cellular regulatory steps affecting these protein-
protein interactions. NSP1 proteins are believed to interact with target proteins by 
specific C-terminal motifs, and analysis of β-TrCP-targeting NSP1 proteins reveals a 
conserved DSGIS motif with notable similarity to the DSGϕxS phosphodegron motif 
conserved within IκB (138). With experimental techniques combining the use of 
phosphospecific antibodies, site directed mutagenesis, and phosphatase treatment, our 
data suggests that NSP1 proteins conserving this motif are indeed phosphorylated. 
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Furthermore, analysis of the surrounding degron context revealed a consensus sequence 
of CKII. With experiments utilizing mutagenesis, RNAi, and a small molecular inhibitor, 
our data demonstrates that phosphorylation is accomplished by CKII. When CKII was 
inhibited, we saw markedly reduced phosphorylation of NSP1 proteins, also suggesting 
that no other cellular kinase utilizes the NSP1 C-terminus as a substrate.  
We next sought to assess the biological relevance of NSP1 phosphorylation by 
addressing NSP1 function in the presence or absence of C-terminal phosphorylation 
modifications. By immunoblot analyses, data demonstrates that unphosphorylated NSP1 
proteins are not able to inhibit β-TrCP activity. Additionally, unphosphorylated NSP1 
proteins are not able to facilitate direct interactions with β-TrCP target proteins, as 
assessed by immunoprecipitation experiments. Most surprising, however, was the 
apparent reliance of CRL incorporation on the phosphorylation of NSP1: 
unphosphorylated NSP1 proteins, despite an intact RING domain, were unable to bind 
cellular Cul3. Together, this data suggests an ordered step-wise process governing NSP1-
incporation into cellular CRLs: (1) NSP1 is bound by CKII and phosphorylated, (2) 
phosphorylation of the degron motif leads to binding by β-TrCP target proteins, (3) the 
NSP1-β-TrCP complex associates with Cul3 CRLs via the N-terminal RING domain, 
releasing CKII, and (4) CRL incorporation leads to β-TrCP ubiquitination and 
degradation.  
In our studies, we observed that NSP1 expression reaches peak levels near 4 h 
p.t., and that this time point also correlates with apparent inhibition of β-TrCP activity, as 
measured by accumulation of p-IκB. Degradation of β-TrCP, however, does not occur 
until much later in infection. This data suggests that binding alone by NSP1 may be 
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enough to inhibit β-TrCP activity, either by sequestration or by ubiquitination 
independent of proteasomal degradation. Interestingly, experiments with an avian RVD 
NSP1 protein indicated that this NSP1 protein was capable of inhibiting NF-κB signaling 
without facilitating degradation of β-TrCP. Together, this data suggests that this 
mechanism may represent an approach adopted by many viral proteins, both within the 
Reoviridae family, but also beyond, including vaccinia and Epstein Barr virus proteins.  
To examine the extent to which mechanisms may be shared between rotavirus 
NSP1 proteins, we next focused our efforts on NSP1 proteins that share similar putative 
RING domains. Our experiments with RVA NSP1 proteins suggest that the RING 
domain bridges interactions with cullin scaffold proteins, whereas the C-terminus of the 
protein identifies substrates for binding and degradation. NSP1 proteins from groups A, 
C, D, and F all share a putative RING domain, but the activity of group C, D, and F NSP1 
proteins as interferon antagonists has not been reported.  
Studies from Ding, et al. and Lutz, et al. report that RVA NSP1 proteins interact 
with cullin proteins and adopt shared mechanisms regardless of substrate protein identity, 
so we assessed whether these non-group A NSP1 proteins had SA11-4F-like or OSU-like 
activity. Specifically, we examined the potential role of non-group A NSP1 proteins as 
antagonists of IRF, NF-κB, and JAK/STAT signaling, beginning with an in silico 
analysis of the protein C-termini. Surprisingly, the NSP1 included in the study did not 
contain canonical C-terminal targeting motifs seen in Group A NSP1 proteins. 
Interestingly, only RVD NSP1 had NF-κB antagonist activity, and was able to restrict 
promoter activation without facilitating degradation of β-TrCP. None of the NSP1 
 
 141 
proteins tested were able to inhibit IRF3 signaling to the same extent that is observed by 
SA11-4F NSP1 proteins, and only RVD NSP1 was able to limit JAK/STAT signaling. 
While additional studies are needed to describe in detail the role of non-RVA 
NSP1 proteins in interferon induction, our observations suggest that multiple NSP1 
proteins from different strains may utilize a similar mechanism to target diverse targets. 
This work builds upon studies by Ding, et al. and Lutz, et al., who have extensively 
studied IRF3-targeting NSP1 proteins, such as those from SA11-4F viruses. However, no 
C-terminal modification was been reported for these NSP1 proteins. Our studies with 
OSU-like NSP1 proteins demonstrate that phosphorylation is required for both substrate 
and CRL engagement, suggesting that a conformational change may govern these binding 
interactions. To this end, we assessed whether the interaction between SA11-4F NSP1 
and IRF3 was similarly governed by phosphorylation.  
 NSP1 proteins from SA11-4F-like strains have within their C-terminal substrate 
targeting domain a conserved pLxIS motif, that is likely a mimic of analogous motif 
utilized by immune adaptor proteins to engage IRF proteins. Cellular proteins containing 
pLxIS motifs are phosphorylated prior to IRF binding, but our in silico analysis of SA11-
4F NSP1 identified no known cellular kinase consensus sequence in this region. 
Furthermore, mutations introduced within the pLxIS motif were unable to inhibit NSP1 
antagonism of IRF3 promoter activation, including mutation of the terminal serine 
residue. These NSP1 proteins remained active when multiple mutations were introduced 
at once.  Instead, our data indicates that these proteins likely forge interactions hinging 




While SA11-4F NSP1 proteins do not appear to be phosphorylated within their C-
terminal targeting domain, our findings do not rule out the possibility that other 
phosphorylation events affect the function of this protein. It is possible that SA11-4F 
NSP1 proteins adopt a conformation that allows them to engage targets and Cullin 
scaffold proteins effectively, and that OSU-like NSP1 proteins instead must undergo 
phosphorylation to catalyze appropriate folding. Additionally, it has been shown that 
phospho-mimetic mutations of OSU NSP1 proteins do not have the same activity of 
wildtype phosphorylated NSP1 proteins (138), suggesting that there may be chemical 
requirements for substrate binding specific to this interaction.  
NSP1 is notoriously difficult to purify, but the suggestion that SA11-4F NSP1 
proteins do not require context-specific modifications suggest the feasibility of 
experimentation with purified peptides. Experiments utilizing NSP1 peptides may be a 
useful tool to study specific protein-protein interactions, as was achieved by Liu, et al, to 
predict and study pLxIS binding to IRF3. This approach will likely be more challenging 
in studies of OSU NSP1 proteins, however. Phosphorylation of the DSGIS motif likely 
affects RING folding, and thus there seem to be long-range interactions between the N-
and C-termini. Such a study would be particularly intriguing in studies of degron binding 
strength. The most common β-TrCP substrate phosphodegron, found within the 
phosphodegron domains of both IκB and HIV Vpu, preserves a distance of three residues 
between the conserved residues of the essential serine doublet (DSGΦXS). Vaccinia A49 
increases this distance to four residues (DSGΦXES), while OSU NSP1 instead opts for 
an abridged DSGΦS motif. Reportedly, glutamic or aspartic acid replacement of serine 
residues increases binding strength for A49 but decreases binding for IκB. Indeed, 
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phosphorylation and charge changes induce necessary conformational changes affecting 
distance within the IκB degron to induce β-TrCP binding (266). The relative binding 
strength of the OSU NSP1 degron motif has not been established, and it has yet to be 
observed if this length modification confers a selective advantage for the virus in terms of 
target binding strength or other sources of regulation. It will be intriguing to examine 
why NSP1 has chosen to mimic a shortened version of this motif, as is found in CREB-H 
(253) and Nrf2 (267) over the degrons of other viral and cellular β-TrCP binding 
partners. The structure of a CREB-H-β-TrCP was recently published (253), and insights 
into this binding may provide a valuable framework by which to assess NSP1-β-TrCP 
complexes.  
β-TrCP is targeted by many viral proteins outside the Reoviridae family, 
including vaccinia and Epstein-Barr viruses, suggesting that the benefits of β-TrCP 
manipulation may not be limited to rotavirus. To this end, we assessed whether β-TrCP 
inhibition resulted in changes in signaling patterns of other cascades known to be 
regulated by β-TrCP activity. Specifically, we found that DEPTOR, an mTOR-associated 
protein whose stability is regulated by β-TrCP, is stabilized during OSU infection, and 
that this observation held true in multiple cell types. OSU infection of both HT29 and 
MA104 cells lead to an increase in DEPTOR, and this effect was limited by the use of 
TBB, suggesting the increase may be due to NSP1 activity. UK, a rotavirus with an NSP1 
with more mild effects on β-TrCP degradation, was unable to facilitate the same effects. 
Similarly, TNF-a treatment also did not result in DEPTOR accumulation.  
Furthermore, immunoblot analysis of infected cell lysates suggest an mTOR 
signaling constellation consistent with extended autophagy also observed during 
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influenza infection. OSU infection caused an increase in phosphorylation of p70-S6K, 
Akt, and 4E-BP1. This phenotype may be indicative of viral control of expanded, lethal 
autophagy, a process that requires mTOR and p70-S6K and has been reported to support 
influenza replication (264). Perhaps this process, too, supports replication of rotavirus 
and indicates induction of an intracellular environment that is broadly pro-viral.  
Progress in the rotavirus field has been long shaped by the lack of a flexible, 
whole-genome reverse genetics (RG) system. While the studies presented here were 
underway, the first report of a rotavirus RG system was published (77). The development 
of this system has significant impacts on the future of the rotavirus field; the introduction 
of this system would profoundly alter the course of action taken in the studies presented 
here. In our examination of NSP1, we have limited the assessment of protein activity to 
mechanisms of antiviral signaling control; however, this protein likely has many 
additional roles in infected cells. Of note, the putative RING domain has RNA-binding 
activity (146, 243), but the precise role this activity plays during replication is unknown. 
This domain has specific affinity for all rotavirus ssRNAs, suggesting that it may play a 
role in evasion of immune detection during replication. Because NSP1 is non-essential to 
rotavirus replication, the introduction of an RG system has particular value in the 
assessment of this protein compared to structural proteins or other essential enzymes. It is 
clear that the universal application of this system will have a great impact on our 
understanding of rotavirus biology; while strides have been made in the elucidation of the 
NSP1 functional landscape and its relationship to multiple aspects of cell biology, there 
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Appendix. Evidence of NSP1 or β-TrCP ubiquitination 
Introduction 
 Cullin-RING ligases (CRLs) are subject to multiple levels of regulation, including 
localization and availability of substrates or other key components. One role of cullin-
associated and neddylation dissociated 1 (Cand1) is to act as an exchange factor for 
adaptor proteins that allows assembly processes to bias towards adaptors for which 
substrates are available (174). Once adaptors have integrated into formed CRLs, 
however, their stability is highly dependent on the availability of substrates (268, 269). F-
box adaptor proteins, in particular, appear to be an unstable protein population and 
readily undergo autophosphorylation when assembled onto CRLs. The HIB adaptor 
protein of Cul3 CRLs, for example, rapidly auto-ubiqutinates when substrates are in short 
supply (268).  
 The rotavirus protein NSP1 likely acts to facilitate degradation of host antiviral 
proteins by acting as a substrate adaptor protein of Cul3 CRLs (148). While several 
studies support a role for NSP1 as a member of a cellular CRL (144, 145, 270), many of 
these data are based upon interpretation of co-immunoprecipitation experiments. NSP1 
cannot be easily purified, so in vitro analyses of this proteins behavior are difficult to 
perform. However, if indeed NSP1 behaves as an adaptor subunit of a hijacked CRL, 
there may be evidence of ubiquitination of the protein, as is observed as the cell regulates 
adaptor subunits of CRLs. To this end, we sought to evaluate the ubiquitination status of 
NSP1 proteins by several techniques, both in the context of infected cells and for 




Materials and methods  
Cells and viruses. Human colorectal HT29 cells were grown in McCoy’s 5A (modified) 
medium containing 10% fetal bovine serum (FBS) (Gibco) and penicillin-streptomycin. 
Rotaviruses were propagated and titered by plaque assay on MA104 cells as described by 
Arnold et al (221). Prior to infection, rotaviruses were activated by treatment with 5 µg 
per ml of porcine pancreas trypsin (type IX-S; Sigma-Aldrich) for 1 h at 37°C.  
  
Antibodies. Rabbit polyclonal antibodies to porcine OSU NSP1 protein (137) and PCNA 
(Santa Cruz Biotech [SCB], sc-7907), rabbit monoclonal antibody to β-TrCP (Cell 
Signaling Technology [CST], #11984S), and mouse monoclonal antibodies to IκB (CST, 
#4814) and p-IκB (CST, #9246) were used at 1:5,000 dilution. HRP-conjugated goat anti-
rabbit IgG antibody (CST, #7074) and horse anti-mouse IgG antibody (CST, #7076) were 
used at 1:10,000 dilution. 
  
Inhibitors. The protein kinase CKII inhibitor, 4,5,6,7-tetrabromobenzotriazole (TBB) 
(Tocris Bioscience) was prepared as 1 mM stocks in dimethyl sulfoxide (DMSO) and 
stored at -20°C. TBB was diluted in cell culture medium to a final concentration of 80 
µM prior to use. MG132 (Sigma) was dissolved in DMSO and diluted in media to a final 
concentration of 15 mM. 
  
Viral infection. Nearly confluent monolayers of HT29 cells in 10 cm2 tissue-culture 
dishes were infected at an MOI of 5 with trypsin-activated rotavirus. After a one-hour 
adsorption incubation, the inoculum was removed and cells were rinsed with PBS. Cell 
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monolayers were then maintained in serum-free McCoy’s 5A (modified) medium until 
specified time of harvest. Lysates were prepared by washing monolayers with cold PBS 
and scraping cells into 0.5 ml RIPA lysis buffer. Lysates were incubated on ice for 10 
min, gently mixed, and clarified by centrifugation for 10 min at 15,000 x g at 4°C. 
 
Immunoblot assay. Protein samples were mixed with NuPAGE LDS sample buffer 
(Invitrogen) containing 50 mM dithiothreitol (DTT), denatured by heating to 70°C for 10 
min, and resolved by electrophoresis on pre-cast 10% Tris-glycine polyacrylamide gels 
(Novex). Molecular weight ladders (SeeBlue Plus2, Invitrogen) were resolved in parallel. 
Proteins were transferred from gels onto nitrocellulose membranes via the iBlot dry 
transfer apparatus (ThermoFisher) according to the manufacturer’s protocol. Membranes 
were blocked by incubation in 5% Carnation dry milk in PBS-0.2% Tween-20 (PBST) 
prior to incubation with primary antibody diluted in milk-PBST. Membranes were 
washed with PBST before incubation with HRP-conjugated secondary antibody in milk-
PBST. Membranes were washed with PBST and developed using Super Signal West Pico 
chemiluminescent substrate (Pierce). Signal was detected by exposing membranes to 
BioExcell X-ray film. 
 
Immunoprecipitation. Nearly confluent monolayers of HT29 cells in 10-cm2 dishes 
were infected as described above. At 4 h p.t., cells were treated with MG132 or DMSO. 
At 8 h p.t., cells were scraped, rinsed twice in PBS, and disrupted by resuspension in IP 
lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% Triton X-100, with 1× 




Figure A-1. Long exposure of immunoblot for proteins in infected cell lysate, including 
high molecular weight NSP1. Adapted from Davis, et al. (148).  HT29 cells infected with 
OSU at an MOI of 5, were treated with TBB or DMSO at 2 h p.i. At 4 and 9 h p.i., cells 
were collected and lysed, and proteins were resolved by electrophoresis and examined by 
immunoblot assay. Altered cropping of the top panel reveals a high molecular weight 
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debris were removed by centrifugation at 14,000 x g for 10 min. Clarified lysates were 
incubated with primary antibody overnight at 4°C with nutation. Fifty µl of a slurry of 
protein A/G magnetic beads (Pierce) were pre-rinsed 3-times with IP wash buffer (150 
mM NaCl, 50 mM Tris-HCl, pH 7.4), and added to clarified cell lysates. After 2 h 
incubation at 25°C with nutation, beads were recovered using a BioRad Surebeads 
magnetic stand and rinsed 3 times with IP wash buffer. Protein was released from beads 
by nutation in IP elution buffer (0.1 M glycine, pH 3.0) for 5 min at 4°C. Eluted proteins 
were analyzed by gel electrophoresis and immunoblot analysis. 
 
Results and discussion 
  In our assessment of NSP1 activity and the reliance of this protein on CKII 
modification in order to engage substrates, we examined NSP1 accumulation in OSU 
infected cells. By western blot, NSP1 levels increase from 4 to 9 h p.i. (Fig A-1). 
Interestingly, immunoblotting with anti-OSU NSP1 primary antibody revealed an 
expected band at 56 kDa, as well as a higher molecular weight band that only appeared 
late in infection when blots were extensively exposed to film. The high molecular weight 
band appeared both in the presence and absence of TBB. This result suggests that OSU 
NSP1 acquires a modification late in infection and is not dependent on NSP1 interaction 
with substrate proteins. 
 To assess whether the suggested NSP1 modification was ubiquitination, we 
infected HT29 cells with OSU rotavirus, and treated infected cells with MG132. 
Immunoprecipitation experiments were the performed by recovering β-TrCP and bound 




Figure A-2. Detection of ubiquitinated substrates in complex with β-TrCP. OSU-infected 
HT29 cells were lysed and immunoprecipitated with anti-β-TrCP antibody bound to 
magnetic beads. Control experiments were done in the absence of β-TrCP antibody. 
Whole cell lysates, immunoprecipitant (IP) fractions, and supernatant (Sup) fractions 



















beads (Fig. A-2). As a control, primary antibody was omitted from some samples. Whole 
cell lysates, immunoprecipitant (IP) fractions, and supernatant fractions were resolved by 
electrophoresis and transferred to nitrocellulose membranes for immunoblot analysis. 
Membranes were then probed for ubiquitin or for β-TrCP. Anti-ubiquitin blots show a 
strong band at approximately 56 kDa in IP fractions. A high molecular weight band can 
be seen in the IP fraction from MG132-treated samples, suggesting polyubiquitination. 
Whole cell lysates as well as supernatant fractions show large high molecular weight 
smears.  Blots probed for β-TrCP indicate a strong band of approximately 56 kDa in IP 
fractions as well as in supernatant fractions.  
 Because β-TrCP and NSP1 form complexes with one another during infection, 
and because these proteins are comparable in size, the band appearing in anti-ubiquitin 
probed IP samples could represent either protein. However, while no shift is observable 
in anti-β-TrCP immunoblots of infected cell lysates, a high molecular weight band is 
observed when probed with anti-OSU NSP1 antibodies. Together, this data suggests that 
NSP1 may auto-ubiquitinate in a fashion that is known to be characteristic of cellular 
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